image_name stringlengths 68 68 | type stringclasses 2
values | gt_table stringlengths 116 12.6k | table_fragment_1 stringlengths 43 8.42k | table_fragment_2 stringlengths 39 8.21k |
|---|---|---|---|---|
16e58f48af650329b495321a26b56e625f511d9dee5a9bdc02ec1d9bd7cf77f4.png | complex | <table><tr><td>Effects and limitations of management contract</td><td>Public sector perspective</td><td>private sector perspective</td></tr><tr><td rowspan="5">Effects</td><td>By introducing competitive forces, contracting puts pressure on both public and private providers in terms of both service and price.</td><td>Co... | <table><tr><td>Effects and limitations of management contract</td><td>Public sector perspective</td><td>private sector perspective</td></tr><tr><td>Effect</td><td>By introducing competitive forces, cont</td><td>C</td></tr></table> | <table><tr><td rowspan="5">s</td><td>racting puts pressure on both public and private providers in terms of both service and price.</td><td>ontracting expands market opportunities to include public sector clients or customers.</td></tr><tr><td>Expanding the range of activities subject to contracting encourages the priv... |
772b165aa6f4730bcf96b4ea4d16d34bef666bf22253825c1c351c25588991b0.png | simple | <table><tr><td></td><td>No. herds</td><td>End of one year study period</td><td>Herd size Cow years/year</td><td>Calculated bulk tank somatic cell count</td><td>Milk production Kg ECM/day</td><td>Mastitis treatments % cows treated/cow year</td><td>% of cows with infection risk > 50%</td></tr><tr><td>Conventional</td>... | <table><tr><td></td><td>No. herds</td><td>End of one year study period</td><td>Herd size Cow years/year</td><td>Calculated bulk tank somatic cell count</td><td>Milk production Kg ECM/day</td><td>Mastitis treatments % cows treated/cow year</td><td>% of cows with infection risk > 50%</td></tr><tr><td>Conventional</td><td... | <table><tr><td>Converting herds first year after conversion</td><td>19</td><td>04–2000 or 04–2001</td><td>101</td><td>337</td><td>23.3c</td><td>52a,b</td><td>44</td></tr><tr><td>Converting herds second year after conversion</td><td>19</td><td>04–2001 or 04–2002</td><td>107</td><td>327</td><td>23.8*</td><td>48a,b</td><t... |
62d6bbdd8229910bb84125346cf05327096d8b161715d34f46ca9e4af27e1cea.png | complex | <table><tr><td rowspan="3">History of blood donation</td><td colspan="2">Blood donation total attitude</td><td rowspan="3"><i>P</i> value<sup>*</sup></td></tr><tr><td colspan="2">score (4–20)</td></tr><tr><td>Median</td><td>Mean rank</td></tr><tr><td>Yes</td><td>16.5</td><td>196.0</td><td rowspan="2"><0.001</t... | <table><tr><td rowspan="3">History of blood donation</td><td colspan="2">Blood donation total attitude</td></tr><tr><td colspan="2">score (4–20)</td></tr><tr><td>Median</td><td>Mean rank</td></tr><tr><td>Yes</td><td>16.5</td><td>196.0</td></tr><tr><td>No</td><td>16</td><td>157.2</td></tr></table> | <table><tr><td rowspan="3">P value*</td></tr><tr></tr><tr></tr><tr><td rowspan="2"><0.001</td></tr><tr></tr></table> |
f69d03ef802b9de3b7c129e1227023a36ed14cd04a4cc45541ddcdd48006b59f.png | simple | <table><tr><td>Sample ID</td><td>MW of standard protein bands (KDa)</td></tr><tr><td><i>C. muytjensii</i>ATCC 51329</td><td>66, 80 & 150</td></tr><tr><td><i>C. sakazakii</i>ATCC 29544</td><td>66, 125</td></tr><tr><td>MP04.1</td><td>66 & 80</td></tr><tr><td>MP08.5</td><td>66, 80,125 & 150</td></tr><tr><td>MP... | <table><tr><td>Sample ID</td><td>MW of standard protein bands (KDa)</td></tr><tr><td>C. muytjensiiATCC 51329</td><td>66, 80 & 150</td></tr><tr><td>C. sakazakiiATCC 29544</td><td>66, 125</td></tr><tr><td>MP04.1</td><td>66 & 80</td></tr><tr><td>MP08.5</td><td>66, 80,125 & 150</td></tr><tr><td>MP10.2</td><td>150</td></tr>... | <table><tr><td>SP62.1</td><td>66, 80,125 and 150</td></tr></table> |
3f242c2a8e349b7a9ee7ec0a4f9a48accbe38988d5fe3751888a6c7b91a632a1.png | simple | <table><tr><td></td><td>Cumulated Dose (μGy) @ 0.152 m</td><td>Cumulated Dose (μGy) @ 0.305 m</td><td>Cumulated Dose (μGy) @ 0.914 m</td></tr><tr><td>1 hr</td><td>87.3</td><td>56.0</td><td>9.9</td></tr><tr><td>2 hr</td><td>147.0</td><td>94.3</td><td>16.6</td></tr><tr><td>3 hr</td><td>188.0</td><td>120.6<... | <table><tr><td></td><td>Cumulated Dose (μGy) @ 0.152 m</td><td>Cumulated Dose (μGy) @ 0.305 m</td><td>Cumulated Dose (μGy) @ 0.914 m</td></tr></table> | <table><tr><td>1 hr</td><td>87.3</td><td>56.0</td><td>9.9</td></tr><tr><td>2 hr</td><td>147.0</td><td>94.3</td><td>16.6</td></tr><tr><td>3 hr</td><td>188.0</td><td>120.6</td><td>21.2</td></tr><tr><td>4 hr</td><td>216.1</td><td>138.6</td><td>24.4</td></tr><tr><td>5 hr</td><td>235.3</td><td>150.9</td><td>26.6</td></tr></... |
8c29f0ee26730031c546b6ea34c78282266afb5a43ccc8b34a6da3f10b745e87.png | complex | <table><tr><td colspan="6">Percentage of 13-to 17-Year-OldGirls Completing HPV Vaccine Series, U.S., 2012</td></tr><tr><td>Range</td><td>State</td><td>Percent</td><td>Range</td><td>State</td><td>Percent</td></tr><tr><td>≥50%</td><td>Rhode Island</td><td>57.7</td><td></td><td>Kentucky</td><td>34.9</td></tr><tr><td... | <table><tr><td colspan="6">Percentage of 13-to 17-Year-OldGirls Completing HPV Vaccine Series, U.S., 2012</td></tr><tr><td>Range</td><td>State</td><td>Percent</td><td>Range</td><td>State</td><td>Percent</td></tr><tr><td>≥50%</td><td>Rhode Island</td><td>57.7</td><td></td><td>Kentucky</td><td>34.9</td></tr><tr><td></td>... | <table><tr><td colspan="6">Percentage of 13-to 17-Year-OldGirls Completing HPV Vaccine Series, U.S., 2012</td></tr><tr><td>Range</td><td>State</td><td>Percent</td><td>Range</td><td>State</td><td>Percent</td></tr><tr><td></td><td>Wisconsin</td><td>37.5</td><td></td><td>Idaho</td><td>27.8</td></tr><tr><td></td><td>Nebras... |
231cdf1a0ea3b28e2c8d6f4c5a7e139a82c15f9550452ecd462d5702d9273b24.png | simple | <table><tr><td>Diagnosis</td><td>Tumour biopsy</td><td>Perilesional skin</td><td>Total</td></tr><tr><td> </td><td>No. of positive/total (%)</td><td>No. of positive/total (%)</td><td>No. of positive/total (%)</td></tr><tr><td>BCC</td><td>31/50 (62)</td><td>24/50 (48)</td><td>55/100 (55)</td></tr><tr><td>SCC</td><td>8/9 ... | <table><tr><td>Diagnosis</td><td>Tumour biopsy</td></tr><tr><td></td><td>No. of positive/total (%)</td></tr><tr><td>BCC</td><td>31/50 (62)</td></tr><tr><td>SCC</td><td>8/9 (89)</td></tr><tr><td>Total</td><td>39/59 (66)</td></tr></table> | <table><tr><td>Perilesional skin</td><td>Total</td></tr><tr><td>No. of positive/total (%)</td><td>No. of positive/total (%)</td></tr><tr><td>24/50 (48)</td><td>55/100 (55)</td></tr><tr><td>6/9 (67)</td><td>14/18 (78)</td></tr><tr><td>30/59 (51)</td><td>69/118 (58)</td></tr></table> |
939624b035bd44315b97f2f0dd7e39bc287af39728867e99b70bdfefc58c182b.png | complex | <table><tr><td rowspan="2">Approach</td><td colspan="10">Number of Links</td></tr><tr><td>2</td><td>3</td><td>4</td><td>5</td><td>6</td><td>7</td><td>8</td><td>9</td><td>10</td><td>All</td></tr><tr><td>ELM</td><td>2.8596</td><td>2.2980</td><td>2.8878</td><td>3.5223</td><td>2.5630</td><td>2.7815</td><td>2.7059</td><td>3... | <table><tr><td rowspan="2">Approach</td><td colspan="10">Number of Links</td></tr><tr><td>2</td><td>3</td><td>4</td><td>5</td><td>6</td><td>7</td><td>8</td><td>9</td><td>10</td><td>All</td></tr><tr><td>ELM</td><td></td><td>2.2</td><td></td><td></td><td>2.56</td><td></td><td>2.70</td><td></td><td>3.5</td><td>2.</td></tr... | <table><tr><td></td><td>2.8596</td><td>980</td><td>2.8878</td><td>3.5223</td><td>30</td><td>2.7815</td><td>59</td><td>3.0009</td><td>630</td><td>7811</td></tr><tr><td>WKNN</td><td>3.3536</td><td>2.5236</td><td>2.7971</td><td>3.6393</td><td>2.8896</td><td>2.9103</td><td>2.9982</td><td>3.5008</td><td>3.5673</td><td>2.999... |
58d485417c4bc3aaa03d2c73385e487733c5bb806645df9f96aacf6818be0b4a.png | complex | <table><tr><td rowspan="2">PAH</td><td rowspan="2">TEF</td><td>Surgeon</td><td> </td><td>AT</td><td> </td></tr><tr><td>PAH<sub>Gas</sub></td><td>PAH<sub>Particle</sub></td><td>PAH<sub>Gas</sub></td><td>PAH<sub>Particle</sub></td></tr><tr><td>Naphthalene</td><td>0.001</td><td>1055</td><td>1.6</td><td>584</td><td>1.1</td... | <table><tr><td rowspan="2">PAH</td><td rowspan="2">TEF</td><td>Surgeon</td><td></td><td>AT</td><td></td></tr><tr><td>PAHGas</td><td>PAHParticle</td><td>PAHGas</td><td>PAHParticle</td></tr><tr><td>Naphthalene</td><td>0.001</td><td>1055</td><td>1.6</td><td>584</td><td>1.1</td></tr><tr><td>Acenaphthylene</td><td>0.001</td... | <table><tr><td rowspan="2">PAH</td><td rowspan="2">TEF</td><td>Surgeon</td><td></td><td>AT</td><td></td></tr><tr><td>PAHGas</td><td>PAHParticle</td><td>PAHGas</td><td>PAHParticle</td></tr><tr><td>Anthracene</td><td>0.01</td><td>22.2</td><td>5.6</td><td>16.7</td><td>4.0</td></tr><tr><td>Fluoranthene</td><td>0.001</td><t... |
70028b8052a1218c02b22a8b0c973ea3d4c3530c95297c9b1056cc5e2be216cc.png | complex | <table><tr><td rowspan="2">Variable</td><td rowspan="2">Category</td><td colspan="2">Fresh samples <i>n</i> (%)</td><td rowspan="2">Paraffin-embedded samples <i>n</i> (%)</td></tr><tr><td>Non-metastatic</td><td>Metastatic</td></tr><tr><td>Age</td><td>< 50 year</td><td>5 (50)</td><td>2 (20)</td><td>8 (15.4)</td></tr>... | <table><tr><td rowspan="2">Variable</td><td rowspan="2">Category</td><td colspan="2">Fresh samples n (%)</td><td rowspan="2">Paraffin-embedded samples n (%)</td></tr><tr><td>Non-metastatic</td><td>Metastatic</td></tr><tr><td>Age</td><td>< 50 year</td><td>5 (50)</td><td>2 (20)</td><td>8 (15.4)</td></tr><tr><td></td><td>... | <table><tr><td>Smoking habit</td><td>No</td><td>4 (40)</td><td>2 (20)</td><td>23 (44.2)</td></tr><tr><td></td><td>Yes</td><td>6 (60)</td><td>8 (80)</td><td>29 (55.8)</td></tr><tr><td>Alcohol consumption</td><td>No</td><td>3 (30)</td><td>1 (10)</td><td>15 (28.8)</td></tr><tr><td></td><td>Yes</td><td>7 (70)</td><td>9 (90... |
8f12784b9c22ae3cc69378364db89d0e085437656dfdc8725bbd46773579c163.png | complex | <table><tr><td>Enrichment Categories</td><td><i>p</i>-Value</td><td>FDR</td><td>Related Genes</td></tr><tr><td colspan="4">GO processes</td></tr><tr><td>Negative regulation of eicosanoid secretion</td><td>7.5 × 10<sup>−9</sup></td><td>3.0 × 10<sup>−6</sup></td><td>Hrh2, F2rl2</td></tr><tr><td>Gluc... | <table><tr><td>Enrichment Categories</td><td>p-Value</td><td>FDR</td><td>Related Genes</td></tr><tr><td colspan="4">GO processes</td></tr></table> | <table><tr><td>Negative regulation of eicosanoid secretion</td><td>7.5 × 10−9</td><td>3.0 × 10−6</td><td>Hrh2, F2rl2</td></tr><tr><td>Glucocorticoid biosynthetic process</td><td>1.6 × 10−8</td><td>3.8 × 10−6</td><td>Cacna1h, Hsd3b1</td></tr><tr><td>Negative regulation of fatty acid transport</td><td>4.1 × 10−8</td><td>... |
8ec8d1ae12d8ceeab263a69c1bc2144b9c83572baff364830d19b430eda26ccb.png | simple | <table><tr><td>Organism</td><td><1 mo</td><td>1-11 mos</td><td>1-55 yrs</td><td>6-12 yrs</td><td>> 12 yrs</td><td>Age Unk</td><td>Total</td><td>% of total</td></tr><tr><td>Streptococcus pneumoniae</td><td>2</td><td>31</td><td>27</td><td>17</td><td>87</td><td>42</td><td>187</td><td>37.18</td></tr><tr><td>Neisseria... | <table><tr><td>Organism</td><td><1 mo</td><td>1-11 mos</td><td>1-55 yrs</td><td>6-12 yrs</td><td>> 12 yrs</td><td>Age Unk</td><td>Total</td><td>% of total</td></tr><tr><td>Streptococcus pneumoniae</td><td>2</td><td>31</td><td>27</td><td>17</td><td>87</td><td>42</td><td>187</td><td>37.18</td></tr></table> | <table><tr><td>Neisseria species</td><td>2</td><td>5</td><td>14</td><td>18</td><td>56</td><td>12</td><td>107</td><td>21.27</td></tr><tr><td>Haemophilus species</td><td>0</td><td>18</td><td>24</td><td>2</td><td>9</td><td>6</td><td>59</td><td>11.73</td></tr><tr><td>Staphylococcus</td><td>0</td><td>10</td><td>6</td><td>2<... |
189496a3df1dc1d3bad3493019dbc5e22914d86d18ff58ff4a8c16e6fdb41443.png | complex | <table><tr><td>Ecological</td><td></td><td colspan="3">Levels</td><td colspan="3">Change in change</td></tr><tr><td>Model</td><td>Dependent variable</td><td>PCNSDP</td><td>PCDE</td><td>HCR</td><td>PCNSDP</td><td>PCDE</td><td>HCR</td></tr><tr><td rowspan="2">1</td><td rowspan="2">Stunting prevalence</td><td>−1.92*... | <table><tr><td>Ecological</td><td></td><td colspan="3">Levels</td><td colspan="3">Change in change</td></tr><tr><td>Model</td><td>Dependent variable</td><td>PCNSDP</td><td>PCDE</td><td>HCR</td><td>PCNSDP</td><td>PCDE</td><td>HCR</td></tr><tr><td>1</td><td>Stunting prevalence</td><td>−1.92**</td><td>–</td><td>–</td><td>... | <table><tr><td>Ecological</td><td></td><td colspan="3">Levels</td><td colspan="3">Change in change</td></tr><tr><td>Model</td><td>Dependent variable</td><td>PCNSDP</td><td>PCDE</td><td>HCR</td><td>PCNSDP</td><td>PCDE</td><td>HCR</td></tr><tr><td>1</td><td>Stunting prevalence</td><td>(0.45)</td><td>–</td><td>–</td><td>(... |
29504a3818a65fe6f63b2d618f25125a44d201a550282874f012180fc6cbed2a.png | simple | <table><tr><td>ID</td><td>Annotation</td><td>290 vs. 5532 fold change</td><td>290 vs. 5532 – <i>p</i>-value corrected FDR</td><td>Normalized expression means 290</td><td>Normalized expression means 5532</td></tr><tr><td>APOBEC3A</td><td>Probable DNA dC- > dU-editing enzyme APOBEC-3A</td><td>1.80E+308</td><td>0... | <table><tr><td>ID</td></tr><tr><td>APOBEC3A</td></tr><tr><td>BLZF1</td></tr><tr><td>BTBD11</td></tr><tr><td>CRLF2</td></tr><tr><td>CSF1</td></tr><tr><td>CXCL10</td></tr><tr><td>CXCL11</td></tr><tr><td>DDX58</td></tr><tr><td>DDX60</td></tr><tr><td>DDX60L</td></tr><tr><td>EIF2AK2</td></tr><tr><td>EPSTI1</td></tr><tr><td>... | <table><tr><td>Annotation</td><td>290 vs. 5532 fold change</td><td>290 vs. 5532 – p-value corrected FDR</td><td>Normalized expression means 290</td><td>Normalized expression means 5532</td></tr><tr><td>Probable DNA dC- > dU-editing enzyme APOBEC-3A</td><td>1.80E+308</td><td>0.022</td><td>0.000</td><td>8.304</td></tr><t... |
6895bf511efaa15bd3b06048fb062f298ebf3bbacfcbfaf601c685e5ce76cd12.png | simple | <table><tr><td>TRT</td><td>Day 10-PC</td><td>Day 23-PC</td><td>Day 28-PC</td><td>Day 36-PC</td><td>Day 50-PC</td><td>Day 10-Stx 1</td><td>Day 10-Stx 2</td><td>Day 10-eae</td><td>Day 23-Stx 1</td><td>Day 23-Stx 2</td><td>Day 23-eae</td><td>Day 28-Stx 1</td><td>Day 28-Stx 2</td><td>Day 28-eae</td></tr><tr><td>Sb1/2e</td>... | <table><tr><td>TRT</td></tr><tr><td>Sb1/2e</td></tr><tr><td>sb1e</td></tr><tr><td>sI1/2e</td></tr><tr><td>sI1e</td></tr><tr><td>so0e</td></tr><tr><td>cb1/2e</td></tr><tr><td>cb1e</td></tr><tr><td>cI1/2e</td></tr><tr><td>cI1e</td></tr><tr><td>co0e</td></tr></table> | <table><tr><td>Day 10-PC</td><td>Day 23-PC</td><td>Day 28-PC</td><td>Day 36-PC</td><td>Day 50-PC</td><td>Day 10-Stx 1</td><td>Day 10-Stx 2</td><td>Day 10-eae</td><td>Day 23-Stx 1</td><td>Day 23-Stx 2</td><td>Day 23-eae</td><td>Day 28-Stx 1</td><td>Day 28-Stx 2</td><td>Day 28-eae</td></tr><tr><td>4.22 ab</td><td>4.11 a<... |
0a6220548389be97a95eb80f23b914ad461c510ab3599f984fdd3eabb2c656b0.png | complex | <table><tr><td>Follow-up periods</td><td colspan="6"><i>P </i>value for lab data</td></tr><tr><td></td><td>Hemoglobin</td><td>TLC</td><td>Platelets</td><td>Bilirubin</td><td>ALT</td><td>AST</td></tr><tr><td>Before therapy versus after 1 month</td><td>0.00</td><td>0.78</td><td>0.19</td><td>0.00</td><td>0.00</td><td>0.00... | <table><tr><td>Follow-up periods</td><td colspan="6">P value for lab data</td></tr><tr><td></td><td>Hemoglobin</td><td>TLC</td><td>Platelets</td><td>Bilirubin</td><td>ALT</td><td>AST</td></tr></table> | <table><tr><td>Before therapy versus after 1 month</td><td>0.00</td><td>0.78</td><td>0.19</td><td>0.00</td><td>0.00</td><td>0.00</td></tr><tr><td>After 1 month versus after 3 months</td><td>0.285</td><td>0.06</td><td>0.25</td><td>0.00</td><td>0.00</td><td>0.00</td></tr><tr><td>After 3 months versus after 6 months</td><... |
0edfbf23bde84ecccb59387786cf2def27d7fa579bfb2a3f9cfbc0c6e1417b15.png | complex | <table><tr><td>Dependent Variable:</td><td colspan="3">Mal_Tot</td><td></td><td colspan="3">Mal_Tot</td><td></td></tr><tr><td>Type of Model</td><td>PRM</td><td></td><td>NBRM</td><td></td><td>PRM</td><td></td><td>NBRM</td><td></td></tr><tr><td>Nobs</td><td>47</td><td></td><td>47</td><td></td><td>47</td><td></td><td>47</... | <table><tr><td>Dependent Variable:</td><td colspan="3">Mal_Tot</td><td></td><td colspan="3">Mal_Tot</td><td></td></tr><tr><td>Type of Model</td><td>PRM</td><td></td><td>NBRM</td><td></td><td>PRM</td><td></td><td>NBRM</td><td></td></tr><tr><td>Nobs</td><td>47</td><td></td><td>47</td><td></td><td>47</td><td></td><td>47</... | <table><tr><td>W:BLT vs (BLT + ENSO ]</td><td>29602.6</td><td>***</td><td>9.2</td><td>***</td><td>24790.4</td><td>***</td><td>5.9</td><td>**</td></tr></table> |
d454a00ec371a502223a6f83ca7d9ddb25c2605ef83ee84236aff0b92ab23d5f.png | simple | <table><tr><td>Species</td><td>GenBank Accession</td><td>Reference</td></tr><tr><td><i>Bathymodiolus azoricus</i></td><td>AF334663</td><td>[70]</td></tr><tr><td><i>B. thermophilus</i></td><td>AF334664</td><td>[70]</td></tr><tr><td><i>Crassostrea virginica 1</i></td><td>AB206328</td><td>[58]</td></tr><tr><td><i>Crassost... | <table><tr><td>Species</td><td>GenBank Accession</td><td>Reference</td></tr><tr><td>Bathymodiolus azoricus</td><td>AF334663</td><td>[70]</td></tr><tr><td>B. thermophilus</td><td>AF334664</td><td>[70]</td></tr><tr><td>Crassostrea virginica 1</td><td>AB206328</td><td>[58]</td></tr><tr><td>Crassostrea virginica 2</td><td>... | <table><tr><td>Mytilus galloprovincialis 1</td><td>AF334665</td><td>[70]</td></tr><tr><td>Mytilus galloprovincialis 2</td><td>AB298451</td><td>Itoh et al. direct submission</td></tr><tr><td>Ostrea edulis</td><td>AB179776</td><td>[96]</td></tr><tr><td>Tapes japonica</td><td>AB091383</td><td>[64]</td></tr></table> |
a892d16baf692a95eba4e046c263ee6a84fbd5dbb69d6388b40b91954886aa2e.png | simple | <table><tr><td>Day of follow up</td><td>0</td><td>1</td><td>2</td><td>3</td><td>7</td><td>14</td><td>21</td><td>28</td></tr><tr><td>Patients assessed at visit</td><td>176</td><td>173</td><td>172</td><td>172</td><td>172</td><td>171</td><td>171</td><td>171</td></tr><tr><td>Loss to follow up</td><td>0</td><td>3</td><td>1<... | <table><tr><td>Day of follow up</td><td>0</td><td>1</td><td>2</td><td>3</td><td>7</td><td>14</td><td>21</td><td>28</td></tr><tr><td>Patients asses</td><td>1</td><td>17</td><td>17</td><td>17</td><td>17</td><td>17</td><td></td><td>171</td></tr></table> | <table><tr><td>sed at visit</td><td>76</td><td>3</td><td>2</td><td>2</td><td>2</td><td>1</td><td>171</td><td></td></tr><tr><td>Loss to follow up</td><td>0</td><td>3</td><td>1</td><td>0</td><td>0</td><td>1</td><td>0</td><td>0</td></tr></table> |
1278d9fe0cb1d629f8ac82be638c2e00b12461d9925144815fdf73025a76309e.png | simple | <table><tr><td>Term</td><td>MAPP Network Research Definition</td></tr><tr><td>Urologic chronic pelvic pain syndrome (UCPPS)</td><td>General term to describe idiopathic chronic pelvic pain of urologic origin in men or women. In MAPP Network studies, this includes men and women with IC/BPS, or men with CP/CPPS (see below... | <table><tr><td>Term</td><td>MAPP Network Research Definition</td></tr><tr><td>Urologic chronic pelvic pain syndrome (UCPPS)</td><td>General term to describe idiopathic chronic pelvic pain of urologic origin in men or women. In MAPP Network studies, this includes men and women with IC/BPS, or men with CP/CPPS (see below... | <table><tr><td>Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS)</td><td>Chronic idiopathic pelvic pain or discomfort in males, commonly in the perineum, suprapubic region, penis, or testicles, which is often exacerbated by ejaculation or urination.</td></tr><tr><td>Non-Urologic Associated Syndromes (NUAS)</td... |
d15fd30871e1d1f18d22324108a3a94a5e200884571af741c6c7d2b6d49ab25f.png | simple | <table><tr><td>Name of classifier</td><td>MNC</td><td>DNC</td><td>TNC</td><td>IPknot<sup>*</sup></td><td>IPknot<sup>#</sup></td></tr><tr><td>BayesNet</td><td>0.073</td><td>0.084</td><td>0.284</td><td>-</td><td>0.397</td></tr><tr><td>NaiveBayes</td><td>0.057</td><td>0.074</td><td>0.058</td><td>0.315</td><td>0.398</td></... | <table><tr><td>Name of classifier</td><td>MNC</td><td>DNC</td><td>TNC</td><td>IPknot*</td><td>IPknot#</td></tr><tr><td>BayesNet</td><td>0.073</td><td>0.084</td><td>0.284</td><td>-</td><td>0.397</td></tr></table> | <table><tr><td>Name of classifier</td><td>MNC</td><td>DNC</td><td>TNC</td><td>IPknot*</td><td>IPknot#</td></tr><tr><td>NaiveBayes</td><td>0.057</td><td>0.074</td><td>0.058</td><td>0.315</td><td>0.398</td></tr><tr><td>MultilayerPerceptron</td><td>0.060</td><td>0.075</td><td>0.128</td><td>0.314</td><td>0.429</td></tr><tr... |
67a994879262a82e5614941ed5b969dc23d19ea0b3a3f0ece405aa876a98dc60.png | complex | <table><tr><td>Dose</td><td>Direction</td><td>Striatum</td><td>Hippocampus</td><td>Cortex</td></tr><tr><td rowspan="2">10 mg/kg</td><td>Up in YAC128, Down with pridopidine</td><td>3.58E-04</td><td>3.78E-04</td><td>2.40E-04</td></tr><tr><td>Down in YAC128, Up with pridopidine</td><td>3.64E-04</td><td>4.99E-02</td><td>2.... | <table><tr><td>Dose</td><td>Direction</td><td>Striatum</td><td>Hippocampus</td><td>Cortex</td></tr><tr><td rowspan="2">10 mg/kg</td><td>Up in YAC128, Down with pridopidine</td><td>3.58E-04</td><td>3.78E-04</td><td>2.40E-04</td></tr><tr><td>Down in YAC128, Up with pridopidine</td><td>3.64E-04</td><td>4.99E-02</td><td>2.... | <table><tr><td>30 mg/kg</td><td>Down in YAC128, Up with pridopidine</td><td>3.37E-04</td><td>3.53E-03</td><td>2.35E-04</td></tr></table> |
05fe72691cce660a0885c0061bb7b84e8e83057ee19bacc836daad2835dd3096.png | complex | <table><tr><td rowspan="2">Saccade Behavior</td><td rowspan="2">Leading Vehicle</td><td colspan="5">Speed (km/h)</td></tr><tr><td>60</td><td>70</td><td>80</td><td>90</td><td>100</td></tr><tr><td rowspan="2">Mean saccade duration (ms)</td><td>Truck</td><td>46.21</td><td>55.92</td><td>58.55</td><td>65.89</td><td>102.51</... | <table><tr><td rowspan="2">Saccade Behavior</td><td rowspan="2">Leading Vehicle</td><td colspan="5">Speed (km/h)</td></tr><tr><td>60</td><td>70</td><td>80</td><td>90</td><td>100</td></tr></table> | <table><tr><td rowspan="2">Mean saccade duration (ms)</td><td>Truck</td><td>46.21</td><td>55.92</td><td>58.55</td><td>65.89</td><td>102.51</td></tr><tr><td>Car</td><td>45.24</td><td>45.99</td><td>51.07</td><td>59.22</td><td>97.69</td></tr><tr><td rowspan="2">Saccade frequency (Hz)</td><td>Truck</td><td>1.02</td><td>1.0... |
4150ab36a9ee6c162aaa94097be7d715ac816367d064e26f4b165385e5a1cd50.png | simple | <table><tr><td>Number</td><td>Age (years)</td><td>Sex</td><td>Primary hematological disorder</td><td>Organs involved by tuberculosis</td><td>Diagnosis of tuberculosis</td><td>Treatment/Outcome of tuberculosis</td></tr><tr><td>1</td><td>55</td><td>Male</td><td>Chronic myeloid leukemia</td><td>Intestine, mesentry and abd... | <table><tr><td>Number</td><td>Age (years)</td><td>Sex</td><td>Primary hematological disorder</td><td>Organs involved by tuberculosis</td></tr><tr><td>1</td><td>55</td><td>Male</td><td>Chronic myeloid leukemia</td><td>Intestine, mesentry and abdominal lymph nodes</td></tr><tr><td>2</td><td>40</td><td>Male</td><td>Acute ... | <table><tr><td>Diagnosis of tuberculosis</td><td>Treatment/Outcome of tuberculosis</td></tr><tr><td>Positive lymph node histology and cultures</td><td>Given/Successful</td></tr><tr><td>Positive sputum cultures</td><td>Given/Successful</td></tr><tr><td>Positive sputum cultures</td><td>Given/Successful</td></tr><tr><td>P... |
cbc0817ae331f048dd498a897dc9e7bd457adcca841473e5b0e3c8feb9e2ead6.png | complex | <table><tr><td rowspan="2">Clinical parameter</td><td colspan="2">AFAP1‐AS1</td><td rowspan="2">Chi‐squared test P value</td></tr><tr><td>High no. cases</td><td>Low no. cases</td></tr><tr><td>Age (years)</td><td></td><td></td><td>0.449</td></tr><tr><td>≤64</td><td>25</td><td>12</td><td></td></tr><tr><... | <table><tr><td rowspan="2">Clinical parameter</td><td colspan="2">AFAP1‐AS1</td><td rowspan="2">Chi‐squared test P value</td></tr><tr><td>High no. cases</td><td>Low no. cases</td></tr><tr><td>Age (years)</td><td></td><td></td><td>0.449</td></tr><tr><td>≤64</td><td>25</td><td>12</td><td></td></tr><tr><td>>64</td><td>25<... | <table><tr><td>5 cm</td><td>7</td><td></td><td></td></tr><tr><td>Tumor stage</td><td></td><td></td><td><0.01</td></tr><tr><td>I</td><td>2</td><td>11</td><td></td></tr><tr><td>II</td><td>27</td><td>4</td><td></td></tr><tr><td>III</td><td>21</td><td>5</td><td></td></tr></table> |
4b8969e51043de2c7994f7a52f69ba7f17259dd02d0b849e146f805289952cec.png | simple | <table><tr><td>Imprecision</td><td>Event</td><td>Original Text</td><td>English Translation</td></tr><tr><td></td><td>Basel, Jul. 1480</td><td>“Anno 1480 circa Magdalenae ingens fuit aquarum inundatio. Rhenus in tantum crevit, quod ad lateres usque inferioris muri Minoris Basileae circa litus ascendit. Etiam homin... | <table><tr><td>Imprecision</td></tr><tr><td></td></tr><tr><td>small</td></tr><tr><td></td></tr><tr><td></td></tr><tr><td>medium</td></tr><tr><td></td></tr><tr><td></td></tr><tr><td>large</td></tr><tr><td></td></tr></table> | <table><tr><td>Event</td><td>Original Text</td><td>English Translation</td></tr><tr><td>Basel, Jul. 1480</td><td>“Anno 1480 circa Magdalenae ingens fuit aquarum inundatio. Rhenus in tantum crevit, quod ad lateres usque inferioris muri Minoris Basileae circa litus ascendit. Etiam homines in ponte stantes facile in Reno ... |
e493d8310bae2ba34b41a962353eda659ea9f2f09c517877926f862a1663c466.png | simple | <table><tr><td> </td><td>n</td><td>Minimum</td><td>Maximum</td><td>Mean</td><td>Std Deviation</td></tr><tr><td>Age (months)</td><td>20</td><td>6.00</td><td>59.00</td><td>39.3500</td><td>18.65</td></tr><tr><td>Weight (Kg)</td><td>20</td><td>6.7</td><td>23.4</td><td>14.9</td><td>4.5</td></tr><tr><td>Temp(<sup>0</sup>C)</... | <table><tr><td></td><td>n</td><td>Minimum</td><td>Maximum</td><td>Mean</td><td>Std Deviation</td></tr><tr><td>Age (months)</td><td>20</td><td>6.00</td><td>59.00</td><td>39.3500</td><td>18.65</td></tr><tr><td>Weight (Kg)</td><td>20</td><td>6.7</td><td>23.4</td><td>14.9</td><td>4.5</td></tr></table> | <table><tr><td></td><td>n</td><td>Minimum</td><td>Maximum</td><td>Mean</td><td>Std Deviation</td></tr><tr><td>Temp(0C)</td><td>20</td><td>35.3</td><td>39.7</td><td>37.8</td><td>1.4</td></tr><tr><td>Par./200 wbc</td><td>20</td><td>56</td><td>3577</td><td>985</td><td>986</td></tr><tr><td>Parasites/μl</td><td>20</td><td>2... |
28df553108167c620a05136d33f34ed9a89099cbc93755bf333ea5ff9ab2c001.png | complex | <table><tr><td></td><td></td><td colspan="3">Low prescribers (<i>n</i> = 408)</td><td colspan="3">High prescribers (<i>n</i> = 408)</td></tr><tr><td></td><td></td><td>Number</td><td>Percent</td><td>[95% confidence interval]</td><td>Number</td><td>Percent</td><td>[95% confidence interval]</td></tr><tr><td rowspan="2">Ge... | <table><tr><td></td><td></td><td colspan="3">Low prescribers (n = 408)</td><td colspan="3">High prescribers (n = 408)</td></tr><tr><td></td><td></td><td>Number</td><td>Percent</td><td>[95% confidence interval]</td><td>Number</td><td>Percent</td><td>[95% confidence interval]</td></tr><tr><td rowspan="2">Gender</td><td>F... | <table><tr><td>Number of patients prescribed a sickness certificate</td><td></td><td>100 [64]</td><td></td><td></td><td>94</td><td></td><td>[50]</td></tr><tr><td>Total volume of reimbursement (number of units)</td><td></td><td>28,247</td><td></td><td>[17,316]</td><td>26,565</td><td></td><td>[14,477]</td></tr><tr><td>Nu... |
e47a8901ee0b2f91bbb34033f9603e660bbc4369b0467a3314f0860c6b5e8742.png | complex | <table><tr><td>Prognostic factor</td><td>N</td><td>Dead over 5 years (%)</td><td>Hazard ratio (95 % CI)</td><td>p</td></tr><tr><td><i>Model-1</i></td><td></td><td></td><td></td><td></td></tr><tr><td>CD8 response to Her-2</td><td></td><td></td><td>0.198 (0.05–1.17)</td><td><i>0.018</i></td></tr><tr><td> Yes</td><t... | <table><tr><td>Prognostic factor</td><td>N</td><td>Dead over 5 years (%)</td><td>Hazard ratio (95 % CI)</td><td>p</td></tr><tr><td>Model-1</td><td></td><td></td><td></td><td></td></tr><tr><td>CD8 response to Her-2</td><td></td><td></td><td>0.198 (0.05–1.17)</td><td>0.018</td></tr><tr><td>Yes</td><td>37</td><td>11</td><... | <table><tr><td></td><td></td><td>11</td><td></td><td></td></tr><tr><td>No</td><td>18</td><td>44</td><td></td><td></td></tr><tr><td>Chemotherapy</td><td></td><td></td><td><0.001 (<0.001–1.67e+130)</td><td>0.941</td></tr><tr><td>Yes</td><td>30</td><td>3</td><td></td><td></td></tr><tr><td>No</td><td>42</td><td>31</td><td>... |
353f75b933e1c364205dac255341a6bb4cba94968a7cd49c2625ef2e9db0a2ab.png | simple | <table><tr><td> </td><td>Total group (n = 1,304)</td><td>No sexual violence (n = 806)</td><td>Rape (n = 183)</td><td>Non-consensual sex (n = 315)</td><td><i>F/χ</i><sup><i>2</i></sup></td></tr><tr><td>Age<sup>†</sup></td><td>15.89 (1.54)</td><td>15.73 (1.49)</td><td>16.34 (1.51)</td><td>16.04 (1.63)</td><td>... | <table><tr><td></td><td>Total group (n = 1,304)</td><td>No sexual violence (n = 806)</td><td>Rape (n = 183)</td><td>Non-consensual sex (n = 315)</td><td>F/χ2</td></tr><tr><td>A</td><td>15</td><td>15.73 (1.</td><td></td><td>1</td><td>13.</td></tr></table> | <table><tr><td>ge†</td><td>.89 (1.54)</td><td>49)</td><td>16.34 (1.51)</td><td>6.04 (1.63)</td><td>90*</td></tr><tr><td>Socio-economic status</td><td></td><td></td><td></td><td></td><td>21.076*</td></tr><tr><td>Bric house</td><td>600 (46.4%)</td><td>404 (50.5%)</td><td>86 (47.5%)</td><td>110 (35.3%)</td><td></td></tr><... |
968640c4ba6c3fb64e266b1f1d42ad3713fadb52855046474422f7177820b7ed.png | complex | <table><tr><td>Item</td><td></td><td>N</td><td colspan="2">Time 1 (Pre)</td><td colspan="2">Time 3 (6 Month)</td><td colspan="2">Mean change*</td><td>P value*</td></tr><tr><td></td><td></td><td></td><td>Mean</td><td>SD</td><td>Mean</td><td>SD</td><td>Mean</td><td>95% CI</td><td></td></tr><tr><td>1</td><td>I am confiden... | <table><tr><td>Item</td><td></td><td>N</td><td colspan="2">Time 1 (Pre)</td><td colspan="2">Time 3 (6 Month)</td><td colspan="2">Mean change*</td><td>P value*</td></tr><tr><td></td><td></td><td></td><td>Mean</td><td>SD</td><td>Mean</td><td>SD</td><td>Mean</td><td>95% CI</td><td></td></tr><tr><td>1</td><td>I am confiden... | <table><tr><td>Item</td><td></td><td>N</td><td colspan="2">Time 1 (Pre)</td><td colspan="2">Time 3 (6 Month)</td><td colspan="2">Mean change*</td><td>P value*</td></tr><tr><td></td><td></td><td></td><td>Mean</td><td>SD</td><td>Mean</td><td>SD</td><td>Mean</td><td>95% CI</td><td></td></tr><tr><td>2</td><td>After seeing ... |
913f1f27b10e7a4453fbfa2f221d363f385cf0ed7ca023864eb2fa1923938222.png | complex | <table><tr><td>Author, year</td><td>Study population (period)</td><td>Definition of HDP-related SAMM</td><td>Case fatality rate (Number of deaths/cases)</td><td colspan="2">Mortality reduction<sup>a</sup></td></tr><tr><td></td><td></td><td></td><td></td><td colspan="2">Natural case fatality</td></tr><tr><td></td><td></... | <table><tr><td>Author, year</td><td>Study population (period)</td><td>Definition of HDP-related SAMM</td><td>Case fatality rate (Number of deaths/cases)</td><td colspan="2">Mortality reductiona</td></tr><tr><td></td><td></td><td></td><td></td><td colspan="2">Natural case fatality</td></tr><tr><td></td><td></td><td></td... | <table><tr><td>l 2008[78]</td><td>pitals in West-Java, Indonesia (2003-2004)</td><td> failure</td><td>22/563)</td><td>4%</td><td>0.7%</td></tr><tr><td>Roost et al 2009[79]</td><td>Four public hospitals in La Paz and El Alto, Bolivia (2006-2007)</td><td>Eclampsia and pre-eclampsia based on clinical and management criter... |
bf927ec997fa9bf50b3e974866562f05d2073b89117151178ac01ed255ca19da.png | simple | <table><tr><td>Characteristic</td><td>Number of patients(%)</td></tr><tr><td>Sex</td><td></td></tr><tr><td>Female</td><td>318 (29.1)</td></tr><tr><td>Male</td><td>775 (70.9)</td></tr><tr><td>Age (years)</td><td></td></tr><tr><td>Median</td><td></td></tr><tr><td>(range)</td><td>47 (15-90)</td></tr><tr><td>≤ 47</td... | <table><tr><td>Characteristic</td><td>Number of patients(%)</td></tr><tr><td>Sex</td><td></td></tr><tr><td>Female</td><td>318 (29.1)</td></tr><tr><td>Male</td><td>775 (70.9)</td></tr><tr><td>Age (years)</td><td></td></tr><tr><td>Median</td><td></td></tr><tr><td>(range)</td><td>47 (15-90)</td></tr><tr><td>≤ 47</td><td>5... | <table><tr><td>Missing</td><td>8</td></tr><tr><td>Follow-up time (months)</td><td></td></tr><tr><td>Median</td><td>67 (1-120)</td></tr><tr><td>(range)</td><td></td></tr><tr><td>Clinical stage</td><td></td></tr><tr><td>I-II</td><td>315 (29.0)</td></tr><tr><td>III-IV</td><td>773 (71.0)</td></tr><tr><td>Missing</td><td>5<... |
735e39658711219c2d97de6f49dcf5022e4023cc7a408111ab1928e91d63db1c.png | complex | <table><tr><td>Group</td><td>Quintile</td><td colspan="2">Total PA</td><td colspan="2">Moderate PA</td><td colspan="2">Vigorous PA</td><td colspan="2">MVPA</td></tr><tr><td> </td><td> </td><td>OR</td><td>95% CI</td><td>OR</td><td>95% CI</td><td>OR</td><td>95% CI</td><td>OR</td><td>95% CI</td></tr><tr><td colspan="10">B... | <table><tr><td>Group</td><td>Quintile</td><td colspan="2">Total PA</td><td colspan="2">Moderate PA</td><td colspan="2">Vigorous PA</td><td colspan="2">MVPA</td></tr><tr><td></td><td></td><td>OR</td><td>95% CI</td><td>OR</td><td>95% CI</td><td>OR</td><td>95% CI</td><td>OR</td><td>95% CI</td></tr></table> | <table><tr><td colspan="10">Boys (2 to 6 years)</td></tr><tr><td rowspan="5">n = 524</td><td>Q1</td><td>2.58</td><td>1.07 to 6.18</td><td>1.26</td><td>0.55 to 2.88</td><td>1.23</td><td>0.46 to 3.26</td><td>1.39</td><td>0.56 to 3.45</td></tr><tr><td>Q2</td><td>1.59</td><td>0.65 to 3.91</td><td>1.27</td><td>0.57 to 2.83<... |
ca8b2161d74a9ac53cafc61edf54e2dc9bc3524609285e4438269d623d60212b.png | simple | <table><tr><td>Parameter</td><td>Benign (n = 102)</td><td>Malignant (n = 11)</td><td>P value</td></tr><tr><td>Age</td><td>58.9 ± 16.4</td><td>48.8 ± 18.7</td><td>0.059</td></tr><tr><td>Female gender</td><td>66 (64.7)</td><td>5 (45.5)</td><td>0.209</td></tr><tr><td>Urgent intervention</td><td>22 (21.6)</td><td... | <table><tr><td>Parameter</td><td>Benign (n = 102)</td><td>Malignant (n = 11)</td><td>P value</td></tr></table> | <table><tr><td>Age</td><td>58.9 ± 16.4</td><td>48.8 ± 18.7</td><td>0.059</td></tr><tr><td>Female gender</td><td>66 (64.7)</td><td>5 (45.5)</td><td>0.209</td></tr><tr><td>Urgent intervention</td><td>22 (21.6)</td><td>10 (90.9)</td><td><0.01</td></tr><tr><td>Coronary artery disease</td><td>8 (7.8)</td><td>0 (0.0)</td><td... |
202e89041409c1bb5b871b76ec48ddda1f665d0249ef69cf0a5a3aa2e336482a.png | simple | <table><tr><td>Hospital</td><td>Case (male/female)</td><td>Percentage of total</td></tr><tr><td>Dongzhimen Hospital affiliated to Beijing University of Chinese Medicine</td><td>178 (111/67)</td><td>5.03%</td></tr><tr><td>Guanganmen Hospital affiliated to China Academy of Chinese Medical Science</td><td>564 (363/201)</t... | <table><tr><td>Hospital</td><td>Case (male/female)</td><td>Percentage of total</td></tr><tr><td>Dongzhimen Hospital affiliated to Beijing University of Chinese Medicine</td><td>178 (111/67)</td><td>5.03%</td></tr><tr><td>Guanganmen Hospital affiliated to China Academy of Chinese Medical Science</td><td>564 (363/201)</t... | <table><tr><td>Hospital</td><td>Case (male/female)</td><td>Percentage of total</td></tr><tr><td>pital University of Medical Sciences</td><td>)</td><td>%</td></tr><tr><td>Wangjing Hospital affiliated to China Academy of Chinese Medical Science</td><td>93 (58/35)</td><td>2.63%</td></tr><tr><td>Xiyuan Hospital affiliated ... |
93f8fafea6b3ecca4bc1bc91985204af2bbe6df6beac28ab0a29702b09c632be.png | complex | <table><tr><td>Cluster of Life Sciences</td><td>BMBS - Biomedicine and Molecular BiosciencesFA - Food and AgricultureFPS - Forests, their Products and Services</td></tr><tr><td>Cluster of Natural Sciences</td><td>CMST - Chemistry and Molecular Sciences and TechnologiesESSEM - Earth System Science and Environmental Mana... | <table><tr><td>Cluster of Life Sciences</td></tr><tr><td>Cluster of Natural Sciences</td></tr><tr><td>Cluster of Science and Society</td></tr><tr><td>Trans Domain area (not a separate Domain currently) – allows for multidisciplinary proposals which cannot be submitted to a single Domain.</td></tr></table> | <table><tr><td>BMBS - Biomedicine and Molecular BiosciencesFA - Food and AgricultureFPS - Forests, their Products and Services</td></tr><tr><td>CMST - Chemistry and Molecular Sciences and TechnologiesESSEM - Earth System Science and Environmental ManagementMPNS - Materials, Physical and Nanosciences</td></tr><tr><td>IS... |
136a5227d7659f62d2266f10f2c2a81a5cdf5fa83ae236695e731f2a5bd14b28.png | simple | <table><tr><td>Chronic Disease (outcome variables)</td><td>Frequent mental distress (FMD) Beta (SE)<sup>1</sup></td><td>Obesity Beta (SE)<sup>1</sup></td></tr><tr><td>Diabetes</td><td>0.55 (0.03)<sup>2</sup></td><td>1.17 (0.02)<sup>2</sup></td></tr><tr><td>High Blood Pressure</td><td>0.54 (0.02)<sup>2</sup></td><td>0.9... | <table><tr><td>Chronic Disease (outcome variables)</td><td>Frequent mental distress (FMD) Beta (SE)1</td><td>Obesity Beta (SE)1</td></tr><tr><td>Diabetes</td><td>0.55 (0.03)2</td><td>1.17 (0.02)2</td></tr><tr><td>High Blood Pressure</td><td>0.54 (0.02)2</td><td>0.99 (0.02)2</td></tr><tr><td>Coronary Heart Disease</td><... | <table><tr><td>Chronic Disease (outcome variables)</td><td>Frequent mental distress (FMD) Beta (SE)1</td><td>Obesity Beta (SE)1</td></tr><tr><td>e</td><td>.04)2</td><td>2</td></tr><tr><td>Asthma</td><td>0.62 (0.03)2</td><td>0.42 (0.02)2</td></tr><tr><td>Arthritis</td><td>0.87 (0.02)2</td><td>0.61 (0.02)2</td></tr></tab... |
fea56b72082c0a771f1d3fb68292f1fb2878936e638e582071338673f10d18ae.png | simple | <table><tr><td>Factor</td><td>Factor level</td><td>Frequency (n)</td><td>Percentage</td><td>Chi-square</td><td>df</td><td>Significance</td></tr><tr><td>Habitat stability</td><td>Permanent</td><td>214</td><td>63.13</td><td></td><td></td><td></td></tr><tr><td></td><td>Temporary</td><td>125</td><td>36.87</td><td>22.317</t... | <table><tr><td>Factor</td><td>Factor level</td><td>Frequency (n)</td><td>Percentage</td><td>Chi-square</td><td>df</td><td>Significance</td></tr><tr><td>Habitat stability</td><td>Permanent</td><td>214</td><td>63.13</td><td></td><td></td><td></td></tr><tr><td></td><td>Temporary</td><td>125</td><td>36.87</td><td>22.317</t... | <table><tr><td>Habitat origin</td><td>Man-made</td><td>326</td><td>96.17</td><td></td><td></td><td></td></tr><tr><td></td><td>Natural</td><td>13</td><td>3.83</td><td>0.873</td><td>1</td><td>0.350</td></tr><tr><td>Water origin</td><td>Surface run-off</td><td>279</td><td>82.30</td><td></td><td></td><td></td></tr><tr><td>... |
458b283d7bf4badabb0701b032f04deee1fea1f11d8f3e699cb1efc7e7454d4e.png | simple | <table><tr><td></td><td>Combined SMI group (n = 230)</td><td>Glasgow City (n = 8,094)</td><td>P<sup>1</sup></td><td>Scotland (n = 54,590)</td><td>P<sup>2</sup></td></tr><tr><td>Cause of death (n, %)</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Cerebrovascular disease</td><td>8 (3.5%)</td><td>304 (3.8%)... | <table><tr><td></td><td>Combined SMI group (n = 230)</td><td>Glasgow City (n = 8,094)</td><td>P1</td><td>Scotland (n = 54,590)</td><td>P2</td></tr><tr><td>Cause of death (n, %)</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Cerebrovascular disease</td><td>8 (3.5%)</td><td>304 (3.8%)</td><td>p = 0.833</td... | <table><tr><td>Other</td><td>0%)</td><td>18.4%)</td><td>76</td><td>9 (18.1%)</td><td>5</td></tr><tr><td>Male (n,%)</td><td>156 (67.8%)</td><td>5218 (64.5%)</td><td>p = 0.298</td><td>33772 (61.9%)</td><td>p = 0.063</td></tr><tr><td>Deaths/age group (n, %)</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>16-... |
7ba8cfa8a2ccbc1e37ea8cefcb1c6f0be4fe04732d07efec23d7776bddea4d86.png | complex | <table><tr><td>Haplotype</td><td>Freq (case)</td><td>Freq (control)</td><td><i>P</i></td><td>OR (95% CI)</td></tr><tr><td colspan="5">rs12068264|rs11576175</td></tr><tr><td> CA</td><td>0.1685 (61)</td><td>0.203 (82)</td><td></td><td>1.000 (Reference)</td></tr><tr><td> TG</td><td>0.4088 (149)</td><td>0.3416 (139)</td><t... | <table><tr><td>Haplotype</td><td>Freq (case)</td><td>Freq (control)</td><td>P</td><td>OR (95% CI)</td></tr></table> | <table><tr><td colspan="5">rs12068264|rs11576175</td></tr><tr><td>CA</td><td>0.1685 (61)</td><td>0.203 (82)</td><td></td><td>1.000 (Reference)</td></tr><tr><td>TG</td><td>0.4088 (149)</td><td>0.3416 (139)</td><td>0.076</td><td>1.441 (0.962–2.158)</td></tr><tr><td>CG</td><td>0.4227 (154)</td><td>0.4554 (185)</td><td>0.5... |
496b3c4834fd018eac0c5cb180d1628133c5fa272de72713167db9c4a4c68cc1.png | complex | <table><tr><td rowspan="2">Compounds</td><td rowspan="2">pIC<sub>50</sub></td><td colspan="2">CoMFA</td><td colspan="2">CoMSIA</td><td colspan="2">HQSAR</td></tr><tr><td>Pred.</td><td>Res.</td><td>Pred.</td><td>Res.</td><td>Pred.</td><td>Res.</td></tr><tr><td>1</td><td>4.1</td><td>4.078</td><td>0.022</td><td>4.331</td>... | <table><tr><td rowspan="2">Compounds</td></tr><tr></tr><tr><td>1</td></tr><tr><td>2</td></tr><tr><td>3</td></tr><tr><td>4</td></tr><tr><td>5</td></tr><tr><td>6</td></tr><tr><td>7</td></tr><tr><td>8</td></tr><tr><td>9</td></tr><tr><td>10</td></tr><tr><td>11</td></tr><tr><td>12</td></tr><tr><td>14</td></tr><tr><td>15</td... | <table><tr><td rowspan="2">pIC50</td><td colspan="2">CoMFA</td><td colspan="2">CoMSIA</td><td colspan="2">HQSAR</td></tr><tr><td>Pred.</td><td>Res.</td><td>Pred.</td><td>Res.</td><td>Pred.</td><td>Res.</td></tr><tr><td>4.1</td><td>4.078</td><td>0.022</td><td>4.331</td><td>− 0.231</td><td>4.204</td><td>− − 0.104</td></t... |
094aa221ab8edabfd42cf1b02883b76a37c447132b0172fbfbde61128f3b86ba.png | simple | <table><tr><td>Demographic characteristics</td><td>Value</td></tr><tr><td>Age in years, mean (range)</td><td>55.9 (42 to 79)</td></tr><tr><td>Race, <i>n</i> (%)</td><td></td></tr><tr><td>White</td><td>4 (50)</td></tr><tr><td>African heritage</td><td>2 (25)</td></tr><tr><td>Asian - Japanese/East Asian/Southeast Asian he... | <table><tr><td>Demographic characteristics</td></tr><tr><td>Age in years, mean (range)</td></tr><tr><td>Race, n (%)</td></tr><tr><td>White</td></tr><tr><td>African heritage</td></tr><tr><td>Asian - Japanese/East Asian/Southeast Asian heritage</td></tr><tr><td>Asian - Central/South Asian heritage</td></tr><tr><td>Baseli... | <table><tr><td>Value</td></tr><tr><td>55.9 (42 to 79)</td></tr><tr><td></td></tr><tr><td>4 (50)</td></tr><tr><td>2 (25)</td></tr><tr><td>1 (13)</td></tr><tr><td>1 (13)</td></tr><tr><td></td></tr><tr><td>6 (77)</td></tr><tr><td>2 (25)</td></tr><tr><td>4.5 (1 to 9)</td></tr></table> |
1e3074383e47208ac2fbdc809fff9af3a7431baacd4047b2c79487dcc6d40d23.png | simple | <table><tr><td>Trial</td><td>Hb (g/L)</td><td>Ferritin (<i>μ</i>g/L)</td><td>TSAT (%)</td><td>BM iron</td></tr><tr><td>Auerbach 2004 [26]</td><td>≤105</td><td>≤200</td><td>≤19*</td><td> ND</td></tr><tr><td>Auerbach 2010 [31]</td><td>≤100</td><td>≥10</td><td>≥15</td><td> ND</td><... | <table><tr><td>Trial</td><td>Hb (g/L)</td><td>Ferritin (μg/L)</td><td>TSAT (%)</td></tr><tr><td>Auerbach 2004 [26]</td><td>≤105</td><td>≤200</td><td>≤19*</td></tr><tr><td>Auerbach 2010 [31]</td><td>≤100</td><td>≥10</td><td>≥15</td></tr><tr><td>Bastit et al. [29]</td><td><110</td><td>10–800</td><td>≥15</td></tr><tr><td>... | <table><tr><td>BM iron</td></tr><tr><td>ND</td></tr><tr><td>ND</td></tr><tr><td>ND</td></tr><tr><td>+</td></tr><tr><td>ND</td></tr><tr><td>ND</td></tr><tr><td>ND</td></tr></table> |
b42d9a98a28d9b8b578a548b21e60b8124aecaadf027b48b0fcd89e37937bb95.png | simple | <table><tr><td>Kidney tissue</td><td>Treatment</td><td>1 h</td><td>24 h</td><td>48 h</td><td>72 h</td></tr><tr><td>Cortex</td><td>CG</td><td>19.0 ± 2.3</td><td>18.9 ± 2.1</td><td>19.2 ± 2.2</td><td>18.9 ± 2.7</td></tr><tr><td> </td><td>DN PC</td><td>24.5 ± 3.6*</td><td>24.5 ± 4.3*</td><td>... | <table><tr><td>Kidney tissue</td><td>Treatment</td><td>1 h</td><td>24 h</td><td>48 h</td><td>72 h</td></tr><tr><td>Cortex</td><td>CG</td><td>19.0 ± 2.3</td><td>18.9 ± 2.1</td><td>19.2 ± 2.2</td><td>18.9 ± 2.7</td></tr><tr><td></td><td>DN PC</td><td>24.5 ± 3.6*</td><td>24.5 ± 4.3*</td><td>24.7 ± 4.5*</td><td>25.4 ± 3.7*... | <table><tr><td>Kidney tissue</td><td>Treatment</td><td>1 h</td><td>24 h</td><td>48 h</td><td>72 h</td></tr><tr><td></td><td>DN 350</td><td>60.6 ± 6.3*</td><td>72.4 ± 5.7*</td><td>62.9 ± 5.5*</td><td>56.5 ± 5.3*</td></tr><tr><td></td><td>DN 400</td><td>67.6 ± 5.6*</td><td>80.4 ± 6.3*</td><td>74.7 ± 6.1*</td><td>67.7 ± 5... |
103dbf17350355d29f4994f0bd2a57039482587d47e6087d78b04ea50381699b.png | complex | <table><tr><td rowspan="2"></td><td>Healthy volunteers</td><td>ObT2D</td><td>HV/ObT2D</td></tr><tr><td>(n = 19)</td><td>(n = 20)</td><td>p value</td></tr><tr><td>Intra-myocardium dixon fat fraction (%)</td><td>7.9 ± 3.7</td><td>6.0 ± 1.5</td><td></td></tr><tr><td>Dixon 3D epicardial fat volume (mL)</td><td>17... | <table><tr><td rowspan="2"></td><td>Healthy volunteers</td><td>ObT2D</td><td>HV/ObT2D</td></tr><tr><td>(n = 19)</td><td>(n = 20)</td><td>p value</td></tr><tr><td>Intra-myocardium dixon fat fraction (%)</td><td>7.9 ± 3.7</td><td>6.0 ± 1.5</td><td></td></tr><tr><td>Dixon 3D epicardial fat volume (mL)</td><td>176.4 ± 68.6... | <table><tr><td rowspan="2"></td><td>Healthy volunteers</td><td>ObT2D</td><td>HV/ObT2D</td></tr><tr><td>(n = 19)</td><td>(n = 20)</td><td>p value</td></tr><tr><td>Indexed dixon 3D epicardial fat volume (mL/m2)</td><td>89.7 ± 25.2</td><td>123.6 ± 23.4</td><td>***</td></tr><tr><td>Dixon 3D epicardial fat fraction (%)</td>... |
760bebfa0c0781c3c2645372d4885f83e19b66cbd91a6b75f5c5e8752894513f.png | complex | <table><tr><td rowspan="2">Name</td><td rowspan="2">Chr</td><td rowspan="2">Bins<sup>a</sup></td><td colspan="2">QTL confidence interval, bp</td><td rowspan="2">LOD<sup>b</sup></td><td rowspan="2">R<sup>2</sup></td><td rowspan="2">Additive Effect<sup>c</sup></td></tr><tr><td>Left border</td><td>Right border</td></tr><t... | <table><tr><td rowspan="2">Name</td><td rowspan="2">Chr</td><td rowspan="2">Binsa</td><td colspan="2">QTL confidence interval, bp</td><td rowspan="2">LODb</td><td rowspan="2">R2</td><td rowspan="2">Additive Effectc</td></tr><tr><td>Left border</td><td>Right border</td></tr><tr><td>QTLGLSchr1</td><td>1</td><td>1.07-1.09... | <table><tr><td rowspan="2">Name</td><td rowspan="2">Chr</td><td rowspan="2">Binsa</td><td colspan="2">QTL confidence interval, bp</td><td rowspan="2">LODb</td><td rowspan="2">R2</td><td rowspan="2">Additive Effectc</td></tr><tr><td>Left border</td><td>Right border</td></tr><tr><td>QTLGLSchr8</td><td>8</td><td>8.02-8.04... |
340262d87015f0f00af5b1d69e85da0b57e35c874e9cd5c4397b261f401711c0.png | complex | <table><tr><td colspan="8">Stage 1: selection of study sites</td></tr><tr><td>Region</td><td>Country</td><td>Estimated no. ART clinics (yr. of assessment)</td><td>Estimated no. adult ART enrollees at ART clinics</td><td>No. eligible clinics*</td><td>Estimated no. study-eligible adult ART enrollees at eligible clinics</... | <table><tr><td colspan="2">Stage 1: selection of study sites</td></tr><tr><td>Region</td><td>Country</td></tr><tr><td rowspan="5">Southern Africa</td><td>Mozambique</td></tr><tr><td>Namibia</td></tr><tr><td>Swaziland</td></tr><tr><td>Zimbabwe</td></tr><tr><td>Zambia</td></tr><tr><td rowspan="2">East Africa</td><td>Tanz... | <table><tr><td colspan="6">Stage 1: selection of study sites</td></tr><tr><td>Estimated no. ART clinics (yr. of assessment)</td><td>Estimated no. adult ART enrollees at ART clinics</td><td>No. eligible clinics*</td><td>Estimated no. study-eligible adult ART enrollees at eligible clinics</td><td>Site sampling technique<... |
9ff8872e63025f9539d6a6ac0e69d9e0420164aee155140bef31ad2610df7564.png | complex | <table><tr><td>CT technique description</td><td colspan="2">Injection activity (MBq)</td><td colspan="2">Effective dose (mSv)</td><td colspan="2">Effective dose per unit activity (mSv/MBq)</td></tr><tr><td></td><td>Male</td><td>Female</td><td>Male</td><td>Female</td><td>Male</td><td>Female</td></tr><tr><td>Standard CT<... | <table><tr><td>CT technique description</td><td colspan="2">Injection activity (MBq)</td><td colspan="2">Effective dose (mSv)</td><td>Effective dose per unit activity (mSv/MBq)</td></tr><tr><td></td><td>Male</td><td>Female</td><td>Male</td><td>Female</td><td>Male</td></tr><tr><td>Standard CT</td><td>455 ± 30</td><td>45... | <table><tr><td>Effective dose per unit activity (mSv/MBq)</td></tr><tr><td>Female</td></tr><tr><td>0.022 ± 0.002</td></tr><tr><td>0.022 ± 0.003</td></tr></table> |
506d7af91bed04831c8b452ee052fc5433d0d70ec55befaa522e77ad078a0886.png | simple | <table><tr><td>Gene Ontology<sup>a</sup></td><td>DAVID<sup>b</sup></td></tr><tr><td>Biological process</td><td></td></tr><tr><td> Cell adhesion (GO:0007155)</td><td>0.0000148</td></tr><tr><td> Cell communication</td><td>0.000632</td></tr><tr><td>G-protein signaling, coupled to cyclic nucleotide second messenger</td><td... | <table><tr><td>Gene Ontologya</td><td>DAVIDb</td></tr><tr><td>Biological process</td><td></td></tr><tr><td>Cell adhesion (GO:0007155)</td><td>0.0000148</td></tr><tr><td>Cell communication</td><td>0.000632</td></tr><tr><td>G-protein signaling, coupled to cyclic nucleotide second messenger</td><td>0.001940c</td></tr><tr>... | <table><tr><td>Signal transducer activity (GO:0004871)</td><td>0.0000025</td></tr><tr><td>Transmembrane receptor activity (GO:0004888)</td><td>0.0000274</td></tr><tr><td>Transmembrane receptor protein phosphatase activity</td><td>0.003811c</td></tr><tr><td>Amine receptor activity</td><td>0.004557c</td></tr><tr><td>Hema... |
5c005d95406c99296920e6430db88edcb6a4ee6eb2322a4f29efeb986c62bdb7.png | complex | <table><tr><td rowspan="2">Outcome and instrument</td><td rowspan="2">Method</td><td colspan="3">Data collection time</td></tr><tr><td>T0</td><td>T1</td><td>T2</td></tr><tr><td>Perceived health</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>SF-36</td><td>Interview caregiver or mailed questionnaire</td><td>x</... | <table><tr><td rowspan="2">Outcome and instrument</td></tr><tr></tr><tr><td>Perceived health</td></tr><tr><td>SF-36</td></tr><tr><td>Objective burden</td></tr><tr><td>Short version iBMG</td></tr><tr><td>instrument objective burden informal care</td></tr><tr><td>Subjective burden</td></tr><tr><td>Carer-Qol</td></tr><tr>... | <table><tr><td rowspan="2">Method</td><td colspan="3">Data collection time</td></tr><tr><td>T0</td><td>T1</td><td>T2</td></tr><tr><td></td><td></td><td></td><td></td></tr><tr><td>Interview caregiver or mailed questionnaire</td><td>x</td><td>x</td><td>x</td></tr><tr><td></td><td></td><td></td><td></td></tr><tr><td>Inter... |
30f1c4f9cd25c2afdb5d58ed1f500c32087e98a26d94dff7326a6ea1facfb5ab.png | simple | <table><tr><td>Strategy</td><td>Treatment</td><td>Genomic Profile</td><td>Phase</td><td>N</td><td>ORR (%)</td><td>PFS (M)</td><td>OS (M)</td><td>Clinical Development</td><td>Reference</td></tr><tr><td>BRAF monotherapy</td><td>Vemurafenib</td><td>BRAFmut</td><td>I/II</td><td>21</td><td>5</td><td>2.1</td><td>7.7</td><td>... | <table><tr><td>Strategy</td><td>Treatment</td><td>Genomic Profile</td><td>Phase</td><td>N</td><td>ORR (%)</td><td>PFS (M)</td><td>OS (M)</td><td>Clinical Development</td><td>Reference</td></tr><tr><td>BRAF monotherapy</td><td>Vemurafenib</td><td>BRAFmut</td><td>I/II</td><td>21</td><td>5</td><td>2.1</td><td>7.7</td><td>... | <table><tr><td>Strategy</td><td>Treatment</td><td>Genomic Profile</td><td>Phase</td><td>N</td><td>ORR (%)</td><td>PFS (M)</td><td>OS (M)</td><td>Clinical Development</td><td>Reference</td></tr><tr><td>MET + EGFR + CT</td><td>Cetuximab + irinotecan ± Tivantinib</td><td>KRAS wt</td><td>I/II (RCT)</td><td>60</td><td>45</t... |
d75b1ad98450517634cf0cbc36463a264616d0653bda0808ef3b8710b47b018a.png | complex | <table><tr><td>Dose level</td><td>N</td><td colspan="3">Radiation therapy dose (Gy)</td><td>Dose delay due to AE</td></tr><tr><td>Level 1</td><td>3</td><td>62</td><td>62<sup>a</sup></td><td>64</td><td>1 (3 days)</td></tr><tr><td rowspan="2">Level 2</td><td>6</td><td>64</td><td>60</td><td>62</td><td rowspan="2">0</td></... | <table><tr><td>Dose level</td><td>N</td><td colspan="3">Radiation therapy dose (Gy)</td><td>Dose delay due to AE</td></tr><tr><td>Level 1</td><td>3</td><td>62</td><td>62a</td><td>64</td><td>1 (3 days)</td></tr><tr><td rowspan="2">Level 2</td><td>6</td><td>64</td><td>60</td><td>62</td><td rowspan="2">0</td></tr><tr><td>... | <table><tr><td>Dose level</td><td>N</td><td colspan="3">Radiation therapy dose (Gy)</td><td>Dose delay due to AE</td></tr><tr><td rowspan="2"></td><td>6</td><td>60</td><td>64</td><td>2</td><td rowspan="2"> (7 days)</td></tr><tr><td></td><td>64</td><td>60b</td><td>62</td></tr></table> |
649b644ef55b583177367b1f6c97850f70cd90df3e75f8b7d72485c69610723e.png | complex | <table><tr><td>Socio -demographic Characteristic</td><td>Number</td><td>%</td></tr><tr><td colspan="3">Age (in years)</td></tr><tr><td> 15–34</td><td>109</td><td>25.6</td></tr><tr><td> 25–34</td><td>166</td><td>39.1</td></tr><tr><td> 35–44</td><td>150</td><td>35.3</td></tr><tr><td colspan="3">Ethnicit... | <table><tr><td>Socio -demographic Characteristic</td><td>Number</td><td>%</td></tr><tr><td colspan="3">Age (in years)</td></tr><tr><td>15–34</td><td>109</td><td>25.6</td></tr><tr><td>25–34</td><td>166</td><td>39.1</td></tr><tr><td>35–44</td><td>150</td><td>35.3</td></tr></table> | <table><tr><td colspan="3">Ethnicity</td></tr><tr><td>Sinhalese</td><td>256</td><td>60.2</td></tr><tr><td>Tamils</td><td>83</td><td>19.5</td></tr><tr><td>Muslims</td><td>80</td><td>18.9</td></tr><tr><td>Burgher & others</td><td>6</td><td>1.4</td></tr><tr><td colspan="3">Religion</td></tr><tr><td>Buddhism</td><td>244</t... |
70215ebb30461f997317514999302a51e0ea3232e52a013ecb3998522f8416a0.png | simple | <table><tr><td>IR score</td><td>A II(<i>n</i> = 6)</td><td>A III(<i>n</i> = 12)</td><td>GBM (<i>n</i> = 55 )</td><td>Control cortex/autopsy (<i>n</i> = 8)</td><td>Control cortex/surgical (<i>n</i> = 5)</td></tr><tr><td>Kir4.1</td><td>3.6 ± 0.85*</td><td>7.18 ± 0.41</td><td>5.5 ± 0.30</td><td>7.13 ± ... | <table><tr><td>IR score</td><td>A II(n = 6)</td><td>A III(n = 12)</td><td>GBM (n = 55 )</td><td>Control cortex/autopsy (n = 8)</td><td>Control cortex/surgical (n = 5)</td></tr><tr><td>Kir4.1</td><td>3.6 ± 0.85*</td><td>7.18 ± 0.41</td><td>5.5 ± 0.30</td><td>7.13 ± 0.36</td><td>7.03 ± 0.26</td></tr></table> | <table><tr><td>IL-1β</td><td>2.46 ± 0.67*</td><td>3.9 ± 0.9*</td><td>3.75 ± 0.45*</td><td>0</td><td>0.02 ± 0.02</td></tr><tr><td>HLA-DR</td><td>5.4 ± 0.77*</td><td>5.7 ± 0.80*</td><td>5.83 ± 0.35*</td><td>0.04 ± 0.02</td><td>0.03 ± 0.02</td></tr></table> |
f60d1856027ab837337768cf7760f611689919354b83dfe0d073cd116bd7acd0.png | complex | <table><tr><td>Category</td><td>Characteristic</td><td>Comparison</td><td>Pre-campaign</td><td>Mid-campaign</td><td>Post-campaign</td></tr><tr><td rowspan="5">Demographics</td><td rowspan="4">Child’s age (months)</td><td>12–23 vs. 0–11</td><td>1.40 (0.98, 2.01)</td><td>1.13 (0.50, 2.57)</td><td>1.07 (... | <table><tr><td>Category</td><td>Characteristic</td><td>Comparison</td><td>Pre-campaign</td><td>Mid-campaign</td><td>Post-campaign</td></tr><tr><td rowspan="5">Demographics</td><td rowspan="4">Child’s age (months)</td><td>12–23 vs. 0–11</td><td>1.40 (0.98, 2.01)</td><td>1.13 (0.50, 2.57)</td><td>1.07 (0.63, 1.81)</td></... | <table><tr><td>Category</td><td>Characteristic</td><td>Comparison</td><td>Pre-campaign</td><td>Mid-campaign</td><td>Post-campaign</td></tr><tr><td rowspan="2">Household health behaviour</td><td>Child reported to have had measles vaccine</td><td>Yes vs. no</td><td>1.12 (0.75, 1.67)</td><td>0.87 (0.28, 2.86)</td><td>5.67... |
c8a7f765f58aa63e6e95b4d899b98a3ccf0541ebc2fe12411088310fdacb2db1.png | simple | <table><tr><td>Assay</td><td></td><td>Primer Sequence 5’-3’</td></tr><tr><td><underline>Pyrosequencing</underline></td><td></td><td></td></tr><tr><td>Assay 1 (20 CpGs)</td><td>Forward</td><td>GGATGTGGGGATTTTTTTTTTTTAGTATAG</td></tr><tr><td></td><td>Reverse</td><td>Biotin-ACTTCAACCCCTCCCCCAAAA</td></tr><tr><... | <table><tr><td>Assay</td><td></td><td>Primer Sequence 5’-3’</td></tr><tr><td>Pyrosequencing</td><td></td><td></td></tr><tr><td>Assay 1 (20 CpGs)</td><td>Forward</td><td>GGATGTGGGGATTTTTTTTTTTTAGTATAG</td></tr><tr><td></td><td>Reverse</td><td>Biotin-ACTTCAACCCCTCCCCCAAAA</td></tr><tr><td></td><td>Sequencing</td><td>TTTT... | <table><tr><td>GAPDH</td><td>Forward</td><td>CATGACAACTTTGGTATCGTG</td></tr><tr><td></td><td>Reverse</td><td>GTGTCGCTGTTGAAGTCAGA</td></tr><tr><td>RASSF1a</td><td>Forward</td><td>CCTCTGTGGCGACTTCATCTG</td></tr><tr><td></td><td>Reverse</td><td>CAACAGTCCAGGCAGACGAG</td></tr><tr><td>MOAP-1</td><td>Forward</td><td>CTCAATTG... |
f2992c4fd7adbcbfdc4390f5ffdadc88c7807d5f4aba8fd45ab3bb351aa5ff8a.png | complex | <table><tr><td rowspan="2">Riparian metric</td><td colspan="2">Mean annual rainfall</td><td colspan="2">Mean annual temperature</td><td colspan="2">Bank height</td><td colspan="2">Proportion of clay</td></tr><tr><td>Estimate</td><td>SE</td><td>Estimate</td><td>SE</td><td>Estimate</td><td>SE</td><td>Estimate</td><td>SE<... | <table><tr><td rowspan="2">Riparian metric</td><td colspan="2">Mean annual rainfall</td><td>Mean annual temperature</td></tr><tr><td>Estimate</td><td>SE</td><td>Estimate</td></tr><tr><td>SPECIES RICHNESS</td><td>0.0347***</td><td>0.009</td><td>0.0238**</td></tr><tr><td>ABUNDANCE</td><td>12.933**</td><td>3.824</td><td><... | <table><tr><td>Mean annual temperature</td><td colspan="2">Bank height</td><td colspan="2">Proportion of clay</td></tr><tr><td>SE</td><td>Estimate</td><td>SE</td><td>Estimate</td><td>SE</td></tr><tr><td>0.0085</td><td>−0.0178</td><td>0.009</td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td><td></td></tr... |
b38362e8f00e7a8fca3904814cf986a595233c65b5f6d8fbce48544490e49b80.png | simple | <table><tr><td> </td><td><i>O. scapulalis</i></td><td><i>O. nubilalis</i></td></tr><tr><td>Raw short sequence number</td><td>322,504</td><td>307,622</td></tr><tr><td>Number after filtering</td><td>287,429</td><td>272,490</td></tr><tr><td>Mean read length (bp)</td><td>352</td><td>356</td></tr><tr><td>Number of singleton... | <table><tr><td></td><td>O. scapulalis</td><td>O. nubilalis</td></tr><tr><td>Raw short sequence number</td><td>322,504</td><td>307,622</td></tr><tr><td>Number after filtering</td><td>287,429</td><td>272,490</td></tr><tr><td>Mean read length (bp)</td><td>352</td><td>356</td></tr><tr><td>Number of singletons</td><td>85,07... | <table><tr><td></td><td>O. scapulalis</td><td>O. nubilalis</td></tr><tr><td>Transcript mean length (bp)</td><td>922</td><td>883</td></tr><tr><td>Transcript median length (bp)</td><td>693</td><td>685</td></tr><tr><td>Transcript N50 length (bp)</td><td>1,036</td><td>991</td></tr><tr><td>Mean exon count per transcript</td... |
5864106145a6b3a4e7bd6fc5595e3bd1ed87c1f032026b83c242566896faaabf.png | simple | <table><tr><td></td><td>Total</td><td>Men</td><td>Women</td></tr><tr><td>Camp (n = 538)</td><td>37.8%</td><td>42.7%</td><td>34%</td></tr><tr><td>Somali (n = 248)</td><td>48.1%</td><td>48.1%</td><td>48.1%</td></tr><tr><td>Rwandese (n = 290)</td><td>32%</td><td>38.9%</td><td>27.3%</td></tr></table> | <table><tr><td></td><td>Total</td><td>Men</td><td>Women</td></tr><tr><td></td><td>3</td><td></td><td>3</td></tr></table> | <table><tr><td>Camp (n = 538)</td><td>7.8%</td><td>42.7%</td><td>4%</td></tr><tr><td>Somali (n = 248)</td><td>48.1%</td><td>48.1%</td><td>48.1%</td></tr><tr><td>Rwandese (n = 290)</td><td>32%</td><td>38.9%</td><td>27.3%</td></tr></table> |
3b870d997043e73b6ff0f08b396ef40c8f7ea4e642bc90964308f8d8ae879485.png | simple | <table><tr><td>Study [reference]: countries</td><td>Population</td><td><i>n</i></td><td>Efficacy</td><td>Lower bound of 95% CI</td><td>Adherence<sup>a</sup></td></tr><tr><td>Partners PrEP [8]: Kenya, Uganda</td><td>Heterosexual couples</td><td>4758</td><td>67% TDF; 75% TDF/FTC</td><td>44% TDF; 55% TDF/FTC</td><td>82%</... | <table><tr><td>Study [reference]: countries</td><td>Population</td><td>n</td></tr><tr><td>Partners PrEP [8]: Kenya, Uganda</td><td>Heterosexual couples</td><td>4758</td></tr><tr><td>TDF2 Study [9]: Botswana</td><td>Young men and women</td><td>1219</td></tr><tr><td>Bangkok TDF [12]: Thailand</td><td>IVDU</td><td>2413</t... | <table><tr><td>Efficacy</td><td>Lower bound of 95% CI</td><td>Adherencea</td></tr><tr><td>67% TDF; 75% TDF/FTC</td><td>44% TDF; 55% TDF/FTC</td><td>82%</td></tr><tr><td>62% TDF/FTC</td><td>21.5%</td><td>80%</td></tr><tr><td>49% TDF</td><td>9.6%</td><td>67%</td></tr><tr><td>44% TDF/FTC</td><td>15%</td><td>51%</td></tr><... |
43164acbcdc1eaea0bce6c68dee39db720b6cf7a8fa5adbe283a5c989b465cbf.png | simple | <table><tr><td>Risk factor</td><td>Crude OR</td><td>Adjusted OR<sup>a</sup></td></tr><tr><td>Own preterm birth<sup>b</sup></td><td>2.10 (1.27–3.48)</td><td>2.32 (1.34–4.03)</td></tr><tr><td>PCOS</td><td>1.44 (1.05–1.97)</td><td>1.07 (0.74–1.54)</td></tr><tr><td>BMI ≥25 kg/m<sup>2</sup></td... | <table><tr><td>Risk factor</td><td>Crude OR</td><td>Adjusted ORa</td></tr><tr><td>Own preterm birthb</td><td>2.10 (1.27–3.48)</td><td>2.32 (1.34–4.03)</td></tr><tr><td>PCOS</td><td>1.44 (1.05–1.97)</td><td>1.07 (0.74–1.54)</td></tr><tr><td>BMI ≥25 kg/m2</td><td>4.87 (4.07–5.84)</td><td>4.22 (3.44–5.18)</td></tr><tr><td... | <table><tr><td>Risk factor</td><td>Crude OR</td><td>Adjusted ORa</td></tr><tr><td>Participant’s father’s T2D</td><td>1.77 (1.37–2.28)</td><td>1.37 (1.03–1.83)</td></tr></table> |
fe32d5b4520c05a7372ae28165da66dea1875d8218a24a0d3f03432cada3766a.png | simple | <table><tr><td></td><td>PANSS positive subscale score</td><td>PANSS negative subscale score</td><td>PANSS general psychopathology subscale score</td><td>PANSS total score</td></tr><tr><td>Serum S100B level changes</td><td>r=0.3P=0.2</td><td>r=-0.048P=0.8</td><td>r=0.05P=0.8</td><td>r=0.06P=0.7</td></tr><tr><td>Leptin (... | <table><tr><td></td><td>PANSS positive subscale score</td><td>PANSS negative subscale score</td><td>PANSS general psychopathology subscale score</td><td>PANSS total score</td></tr><tr><td>Serum S100B level</td><td>r=0.3P</td><td>r=-0.048P=</td><td>r=0.05P=</td><td>r=0.06</td></tr></table> | <table><tr><td> changes</td><td>=0.2</td><td>0.8</td><td>0.8</td><td>P=0.7</td></tr><tr><td>Leptin (microg/ml)</td><td>r=-0.3P=0.1</td><td>r=-0.023P=0.9</td><td>r=-0.2P=0.2</td><td>r=-0.3P=0.1</td></tr></table> |
d13c93a35fe94e97dfcdc48233d9d8151d4800b18130111fcaad49549a893577.png | complex | <table><tr><td>SH3 domain</td><td>k<sub>a </sub>(M<sup>-1</sup>s<sup>-1</sup>) × 10<sup>5</sup></td><td>k<sub>d </sub>(s<sup>-1</sup>) × 10<sup>-2</sup></td><td>K<sub>D </sub>(μM)</td><td>Nef concentrations (μM)</td></tr><tr><td colspan="5">Nef-SF2</td></tr><tr><td>Human Hck SH3</td><td>1.60 ± ... | <table><tr><td>SH3 domain</td><td>ka (M-1s-1) × 105</td><td>kd (s-1) × 10-2</td><td>KD (μM)</td><td>Nef concentrations (μM)</td></tr><tr><td colspan="5">Nef-SF2</td></tr><tr><td>Human Hck SH3</td><td>1.60 ± 0.06</td><td>1.18 ± 0.04</td><td>0.07 ± 0.01</td><td>0, 0.007, 0.02, 0.062, 0.19, 0.56, 1.67, 5.0</td></tr><tr><t... | <table><tr><td>use Hck HART</td><td>4.20 ± 1.40</td><td>43 ± 0.01</td><td>0</td><td> 0.02, 0.062, 0.19</td></tr><tr><td colspan="5">Nef-Consensus*</td></tr><tr><td>Human Hck SH3</td><td>10.00 ± 0.80</td><td>11.80 ± 0.20</td><td>0.12 ± 0.01</td><td>0, 0.02, 0.062, 0.19, 0.56, 1.67, 5.0</td></tr><tr><td>Mouse Hck SH3</td... |
7815e9c50c65dd5ac8ed5848194f01a1a18bb86e191597929d0ac41dd780d156.png | complex | <table><tr><td></td><td colspan="2">Run 1</td><td colspan="2">Run 2</td><td colspan="2">Summary</td></tr><tr><td>HRM</td><td>n</td><td>%</td><td>n</td><td>%</td><td>n</td><td>%</td></tr><tr><td> Number of samples</td><td>120</td><td>100.0</td><td>20</td><td>100.0 (16.7)</td><td>120</td><td>100.0</td></tr><tr><td> Analy... | <table><tr><td></td><td colspan="2">Run 1</td><td colspan="2">Run 2</td><td colspan="2">Summary</td></tr><tr><td>HRM</td><td>n</td><td>%</td><td>n</td><td>%</td><td>n</td><td>%</td></tr><tr><td>Number of samples</td><td>120</td><td>100.0</td><td>20</td><td>100.0 (16.7)</td><td>120</td><td>100.0</td></tr><tr><td>Analysi... | <table><tr><td></td><td colspan="2">Run 1</td><td colspan="2">Run 2</td><td colspan="2">Summary</td></tr><tr><td>Mutant</td><td>4</td><td>22.2</td><td>1</td><td>50.0</td><td>5</td><td>27.8</td></tr><tr><td>Analysis failed</td><td>1</td><td>5.3</td><td>1</td><td>33.3</td><td>1</td><td></td></tr><tr><td>Combined HRM + Py... |
c6dea827be254382b331763c1a9b420262784d5db6fa347f5f68a583869b54d2.png | simple | <table><tr><td>URL structure</td><td>Get</td><td>Post</td><td>Delete</td></tr><tr><td>/namespace/object_type/</td><td>List objects, apply filters</td><td>Create new object or make bulk update</td><td>Bulk delete</td></tr><tr><td>/namespace/object_type/id/</td><td>Access single object</td><td>Update single object</td><t... | <table><tr><td>URL </td><td>Ge</td><td>Pos</td><td></td></tr></table> | <table><tr><td>structure</td><td>t</td><td>t</td><td>Delete</td></tr><tr><td>/namespace/object_type/</td><td>List objects, apply filters</td><td>Create new object or make bulk update</td><td>Bulk delete</td></tr><tr><td>/namespace/object_type/id/</td><td>Access single object</td><td>Update single object</td><td>Delete ... |
604cd5b58c8272c6f7b1234160448daf00e4b6629db172f3d907e332216e6b34.png | complex | <table><tr><td rowspan="2">Parameters</td><td colspan="4">Groups</td><td colspan="3"><i>p</i>values</td></tr><tr><td>Control</td><td>Control + Ucche</td><td>CCl<sub>4</sub></td><td>CCl<sub>4</sub> + Ucche</td><td>CCl<sub>4</sub></td><td>Treatment</td><td>Interaction</td></tr><tr><td colspan="5">Plasma</td><td></td><td>... | <table><tr><td rowspan="2">Parameters</td><td colspan="4">Groups</td><td colspan="3">pvalues</td></tr><tr><td>Control</td><td>Control + Ucche</td><td>CCl4</td><td>CCl4 + Ucche</td><td>CCl4</td><td>Treatment</td><td>Interaction</td></tr><tr><td colspan="5">Plasma</td><td></td><td></td><td></td></tr><tr><td>AST(U/L)</td>... | <table><tr><td rowspan="2">Parameters</td><td colspan="4">Groups</td><td colspan="3">pvalues</td></tr><tr><td>Control</td><td>Control + Ucche</td><td>CCl4</td><td>CCl4 + Ucche</td><td>CCl4</td><td>Treatment</td><td>Interaction</td></tr><tr><td>ALP(U/L)</td><td>.3</td><td>92 ± 2.76</td><td> 6.1</td><td>3.9 ± 4.7</td><td... |
33e2b7381836411134d88f74b58592624a6371ad295a8e4ac6d4ed8f0d0e73da.png | complex | <table><tr><td rowspan="2"></td><td></td><td>Gender</td><td></td></tr><tr><td>Female</td><td>Male</td><td>Total</td></tr><tr><td colspan="4">Need for treatment</td></tr><tr><td> Discussed and confirmed<sup>a</sup></td><td>17</td><td>36</td><td>53</td></tr><tr><td> Discussed, not confirmed</td><td>0</td><td>0</td><td>0<... | <table><tr><td rowspan="2"></td><td></td><td>Gender</td><td></td></tr><tr><td>Female</td><td>Male</td><td>Total</td></tr><tr><td colspan="4">Need for treatment</td></tr></table> | <table><tr><td>Discussed and confirmeda</td><td>17</td><td>36</td><td>53</td></tr><tr><td>Discussed, not confirmed</td><td>0</td><td>0</td><td>0</td></tr><tr><td>Not mentioned</td><td>1</td><td>0</td><td>1</td></tr><tr><td colspan="4">Danger to self</td></tr><tr><td>Discussed and confirmed</td><td>2</td><td>2</td><td>4... |
f5a7b7a517417ce42b722aa065721d4aa28aa9072e24423f4be68e3a6344c32e.png | complex | <table><tr><td colspan="2">RTI/STI symptomatic currently or within last 3 months</td><td>n = 353</td><td>%</td></tr><tr><td>Sought care for RTI/STI symptoms</td><td></td><td></td><td></td></tr><tr><td> Yes</td><td></td><td>238</td><td>67.4</td></tr><tr><td> No</td><td></td><td>115</td><td>32.6</td></tr><tr><td>Time del... | <table><tr><td colspan="2">RTI/STI symptomatic currently or within last 3 months</td><td>n = 353</td><td>%</td></tr><tr><td>Sought care for RTI/STI symptoms</td><td></td><td></td><td></td></tr><tr><td>Yes</td><td></td><td>238</td><td>67.4</td></tr><tr><td>No</td><td></td><td>115</td><td>32.6</td></tr></table> | <table><tr><td colspan="2">RTI/STI symptomatic currently or within last 3 months</td><td>n = 353</td><td>%</td></tr><tr><td>Time delay until seeking care (days)</td><td>(n = 238)</td><td></td><td></td></tr><tr><td>Mean: 10.2</td><td>(range: 2-60)</td><td></td><td></td></tr><tr><td>< 7</td><td></td><td>137</td><td>57.6<... |
b33293758f8d7871b7694dcb800e9b75c904426bc0a9827d35af13c66313490b.png | simple | <table><tr><td>Compound</td><td>IC<sub>50</sub> [μM]</td><td>log P</td></tr><tr><td>2a</td><td>≥100</td><td>3.32</td></tr><tr><td>2b</td><td>58</td><td>3.48</td></tr><tr><td>2c</td><td>≥100</td><td>3.88</td></tr><tr><td>2d</td><td>≥100</td><td>3.81</td></tr><tr><td>3a</td><td>49</td><td>3.89</td>... | <table><tr><td>Compound</td><td>IC50 [μM]</td><td>log P</td></tr><tr><td>2a</td><td>≥100</td><td>3.32</td></tr><tr><td>2b</td><td>58</td><td>3.48</td></tr><tr><td>2c</td><td>≥100</td><td>3.88</td></tr><tr><td>2d</td><td>≥100</td><td>3.81</td></tr><tr><td>3a</td><td>49</td><td>3.89</td></tr><tr><td>3b</td><td>63</td><td... | <table><tr><td>4</td><td>>1000</td><td>4.28</td></tr><tr><td>5</td><td>≥100</td><td>4.74</td></tr><tr><td>cisplatin</td><td>5</td><td></td></tr></table> |
5b4a815eb52c7d71ed6298ee568235340a7827618c35ec6a7d59561b07fc091f.png | simple | <table><tr><td> </td><td>LBD alone (<i>n</i> = 62)</td><td>EST plus LBD (<i>n</i> = 69)</td><td><i>P </i>value</td></tr><tr><td>Diameter of inflated balloon (mm)</td><td>15.9 ± 2.3 (12-20)</td><td>16.2 ± 2.5 (12-20)</td><td>0.444</td></tr><tr><td>Complete stone removal irrespective of whether ML was used, no.... | <table><tr><td></td><td>LBD alone (n = 62)</td><td>EST plus LBD (n = 69)</td><td>P value</td></tr><tr><td>Diameter of inflated balloon (mm)</td><td>15.9 ± 2.3 (12-20)</td><td>16.2 ± 2.5 (12-20)</td><td>0.444</td></tr><tr><td>Complete stone removal irrespective of whether ML was used, no. (%)</td><td>60 (96.8)</td><td>6... | <table><tr><td></td><td>LBD alone (n = 62)</td><td>EST plus LBD (n = 69)</td><td>P value</td></tr><tr><td>Complete stone removal without ML, no. (%)</td><td>50 (80.6)</td><td>51 (73.9)</td><td>0.360</td></tr></table> |
907b22656c1991f098faf8a4ce2099836189cd9db54fd1a51b53775ee926caa1.png | simple | <table><tr><td>Disease class</td><td>Nt</td><td>Nur</td><td>F<sub>IC</sub></td></tr><tr><td>Gastrointestinal</td><td>17</td><td>145</td><td>0.88</td></tr><tr><td>Respiratory</td><td>5</td><td>15</td><td>0.71</td></tr><tr><td>Wound healing</td><td>2</td><td>3</td><td>0.50</td></tr><tr><td>Dermatological</td><td>1</td><t... | <table><tr><td>Disease class</td><td>Nt</td><td>Nur</td></tr><tr><td>Gastrointestinal</td><td>17</td><td>145</td></tr><tr><td>Respiratory</td><td>5</td><td>15</td></tr><tr><td>Wound healing</td><td>2</td><td>3</td></tr><tr><td>Dermatological</td><td>1</td><td>2</td></tr><tr><td>Kidney problems</td><td>2</td><td>4</td><... | <table><tr><td>FIC</td></tr><tr><td>0.88</td></tr><tr><td>0.71</td></tr><tr><td>0.50</td></tr><tr><td>1.00</td></tr><tr><td>0.66</td></tr><tr><td>0.66</td></tr><tr><td>1.00</td></tr><tr><td>1.00</td></tr><tr><td>0.75</td></tr><tr><td>0.60</td></tr><tr><td>1.00</td></tr><tr><td>1.00</td></tr></table> |
3172a15af89116a592dc0f927ef943af8afd74f658da1ebeec33374911710b25.png | simple | <table><tr><td>Phenotype</td><td>n</td><td>CaseAverageRelatedness</td><td>MeanControlAverageRelatedness</td><td>Empiricalp-valueGIF</td><td>Empiricalp-valueDistantGIF</td></tr><tr><td>CFS</td><td>811</td><td>3.15</td><td>2.31</td><td>< 0.001</td><td>0.010</td></tr></table> | <table><tr><td>Phenotype</td><td>n</td><td>CaseAverageRelatedness</td><td>MeanControlAverageRelatedness</td><td>Empiricalp-valueGIF</td><td>Empiricalp-valueDistantGIF</td></tr></table> | <table><tr><td>CFS</td><td>811</td><td>3.15</td><td>2.31</td><td>< 0.001</td><td>0.010</td></tr></table> |
054d70103d536544e30fc98e71598062247069f890796dd5e2c02190180919cd.png | simple | <table><tr><td>Variable</td><td>1<sup>st</sup> quarterN (%)</td><td>2<sup>nd</sup> quarterN (%)</td><td>3<sup>rd</sup> quarter(N%)</td><td>4<sup>th</sup> quarter(N%)</td><td>TotalN (%)</td><td>P value</td></tr><tr><td>Age(years)</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>≤ 15</td><td>2... | <table><tr><td>Variable</td><td>1st quarterN (%)</td><td>2nd quarterN (%)</td><td>3rd quarter(N%)</td><td>4th quarter(N%)</td><td>TotalN (%)</td><td>P value</td></tr><tr><td>Age(years)</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>≤ 15</td><td>200 (12.3)</td><td>201 (12.9)</td><td>275 (17.5)</t... | <table><tr><td>Variable</td><td>1st quarterN (%)</td><td>2nd quarterN (%)</td><td>3rd quarter(N%)</td><td>4th quarter(N%)</td><td>TotalN (%)</td></tr><tr><td>Civil servants</td><td>331 (20.3)</td><td>321 (20. 6)</td><td>327 (20.9)</td><td>258 (20. 5)</td><td>1,237 (20. 6)</td></tr><tr><td>Private workers</td><td>466 (2... |
be1adb1b4f443ce4cfed8fe1d683ab9253f58aa4d0e3e2c73444658f468b7fd6.png | simple | <table><tr><td> </td><td> </td><td> </td><td>Normal PI</td><td>Low PI</td></tr><tr><td>Restricted growth parameters</td><td>Subclass of SGA</td><td>N</td><td>no (%)</td><td>no (%)</td></tr><tr><td>Weight, length and OFC</td><td>Symmetrical</td><td>1</td><td>1 (100.0)</td><td>0 (0.0)</td></tr><tr><td>Weight and length a... | <table><tr><td></td><td></td></tr><tr><td>Restricted growth parameters</td><td>Subclass of SGA</td></tr><tr><td>Weight, length and OFC</td><td>Symmetrical</td></tr><tr><td>Weight and length alone</td><td>Symmetrical</td></tr><tr><td>Weight alone</td><td>Asymmetrical</td></tr></table> | <table><tr><td></td><td>Normal PI</td><td>Low PI</td></tr><tr><td>N</td><td>no (%)</td><td>no (%)</td></tr><tr><td>1</td><td>1 (100.0)</td><td>0 (0.0)</td></tr><tr><td>25</td><td>23 (92.0)</td><td>2 (8.0)</td></tr><tr><td>33</td><td>20 (60.6)</td><td>13 (39.4)</td></tr></table> |
376063842474141d4d084746ce80b4ee3dfc2cb99660a8cad019ac27655878d8.png | complex | <table><tr><td rowspan="2">Amino acid substituted in Y114</td><td colspan="2">37 °C</td><td colspan="2">65 °C<sup>a</sup></td></tr><tr><td>Isomerase activity (mM/min μg)</td><td>Epimerase activity (mM/min μg)</td><td>Isomerase activity (mM/min μg)</td><td>Epimerase activity (mM/min μg)</td... | <table><tr><td rowspan="2">Amino acid substituted in Y114</td><td colspan="2">37 °C</td><td colspan="2">65 °Ca</td></tr><tr><td>Isomerase activity (mM/min μg)</td><td>Epimerase activity (mM/min μg)</td><td>Isomerase activity (mM/min μg)</td><td>Epimerase activity (mM/min μg)</td></tr><tr><td>Y (parent)</td><td>15.6 ± 1... | <table><tr><td rowspan="2">Amino acid substituted in Y114</td><td colspan="2">37 °C</td><td colspan="2">65 °Ca</td></tr><tr><td>Isomerase activity (mM/min μg)</td><td>Epimerase activity (mM/min μg)</td><td>Isomerase activity (mM/min μg)</td><td>Epimerase activity (mM/min μg)</td></tr><tr><td>P</td><td>1.95 ± 0.55</td><... |
f77a8e6ff504f979461164daaecef32f8de435c7ab7abed306d93d065f2f86ba.png | simple | <table><tr><td>References</td><td>Primary outcomes</td><td>Secondary outcomes</td></tr><tr><td>Song (weak)<sup>1</sup>[44]</td><td>Recalled stocking and sales scores were higher in intervention stores than in control stores.</td><td>There was improvement in some specific mediator factors but not in overall mediator fac... | <table><tr><td>References</td><td>Primary outcomes</td><td>Secondary outcomes</td></tr><tr><td>Song (weak)1[44]</td><td>Recalled stocking and sales scores were higher in intervention stores than in control stores.</td><td>There was improvement in some specific mediator factors but not in overall mediator factors.</td><... | <table><tr><td>Gittelsohn 2010b (weak) [42]</td><td></td><td>No changes were shown in most mediator factors between intervention and control stores.</td></tr><tr><td>Ayala 2013 (moderate)2[29]</td><td>The intervention increased availability of vegetables but not fruit.</td><td>Self-efficacy for consuming more fruits de... |
92f1b1c950f23997695b7d8a44b0711c5491a63b373486acb3a40527221d36ae.png | simple | <table><tr><td></td><td>Tree 1</td><td>Tree 2</td><td>Tree 3</td><td>Pfam</td></tr><tr><td>Average sequence identity</td><td>19%</td><td>30%</td><td>42%</td><td>-</td></tr><tr><td>Alignment length</td><td>1080</td><td>629</td><td>597</td><td>404</td></tr><tr><td>Sequence length</td><td>173</td><td>177</td><td>169</td><... | <table><tr><td></td><td>Tree 1</td><td>Tree 2</td><td>Tree 3</td><td>Pfam</td></tr><tr><td>Average sequence identity</td><td>19%</td><td>30%</td><td>42%</td><td>-</td></tr><tr><td>Alignment length</td><td>1080</td><td>629</td><td>597</td><td>404</td></tr><tr><td>Sequence length</td><td>173</td><td>177</td><td>169</td><... | <table><tr><td>Average number of sequences after MaxAlign</td><td>14.1</td><td>22.6</td><td>28.8</td><td>-</td></tr><tr><td>Average number of indels per sequence</td><td>66.6</td><td>54.3</td><td>48.5</td><td>32</td></tr><tr><td>Average length of indels</td><td>13.6</td><td>8.3</td><td>8.8</td><td>7</td></tr></table> |
be8f3e5397e2ce1b30a90e3cdcd2dca43d9ebdbb9fcc8b958b0ee608c351a84d.png | complex | <table><tr><td><i>Expression level</i></td><td colspan="3"><i>Overall survival</i></td></tr><tr><td> </td><td><i>Median survival (95% CI, months)</i></td><td><i>Log-rank P</i></td><td><i>HR (95% CI)</i></td></tr><tr><td>Low ERCC1</td><td>11.7(2.6-15.3)</td><td>-</td><td>-</td></tr><tr><td>High ERCC1</td><td>17.4(4.3-22... | <table><tr><td>Expression level</td><td colspan="3">Overall survival</td></tr></table> | <table><tr><td></td><td>Median survival (95% CI, months)</td><td>Log-rank P</td><td>HR (95% CI)</td></tr><tr><td>Low ERCC1</td><td>11.7(2.6-15.3)</td><td>-</td><td>-</td></tr><tr><td>High ERCC1</td><td>17.4(4.3-22.6)</td><td>0.03</td><td>0.63(0.35-0.88)</td></tr><tr><td>Low RRM1</td><td>13.5(3.2-16.4)</td><td>-</td><td... |
977b950dafe6d713aef1d078ef9484b02d7240c6f521a8191519fdf76be03ec1.png | simple | <table><tr><td>Compounds</td><td>KB <sup>b</sup></td><td>A549 <sup>b</sup></td><td>Compounds</td><td>KB <sup>b</sup></td><td>A549 <sup>b</sup></td></tr><tr><td>Etoposide <sup>c</sup></td><td>0.85 ± 0.08</td><td>0.99 ± 0.09</td><td>C5</td><td>2.45 ± 0.41</td><td>5.24 ± 1.12</td></tr><tr><td>T2</td><t... | <table><tr><td>Compounds</td><td>KB b</td><td>A549 b</td><td>Compounds</td><td>KB b</td><td>A549 b</td></tr><tr><td>Etoposid</td><td>0.85 ±</td><td>0.99 </td><td>C</td><td>2.45 ± 0.41</td><td>5.2</td></tr></table> | <table><tr><td>e c</td><td> 0.08</td><td>± 0.09</td><td>5</td><td></td><td>4 ± 1.12</td></tr><tr><td>T2</td><td>0.58 ± 0.07</td><td>>50</td><td>C6</td><td>8.52 ± 1.41</td><td>12.88 ± 1.32</td></tr><tr><td>S1</td><td>>50</td><td>>50</td><td>C7</td><td>3.80 ± 0.46</td><td>3.67 ± 0.66</td></tr><tr><td>S2</td><td>>50</td><... |
5c15c19cf7e291e9646d4f8ceff67e0376cea3aa2a5b24f638883c75bd6384ea.png | simple | <table><tr><td>Baseline</td><td>Pre App</td><td>App</td><td>Post App</td></tr><tr><td>Complete DASS-21</td><td>Rate subjective wellbeing and distress daily for 7 days</td><td>Rate subjective wellbeing and distress daily for 7 days</td><td>Complete DASS-21</td></tr><tr><td></td><td>Complete DASS-21 after 7 days</td><td>... | <table><tr><td>Baseline</td><td>Pre App</td><td>App</td><td>Post App</td></tr></table> | <table><tr><td>Complete DASS-21</td><td>Rate subjective wellbeing and distress daily for 7 days</td><td>Rate subjective wellbeing and distress daily for 7 days</td><td>Complete DASS-21</td></tr><tr><td></td><td>Complete DASS-21 after 7 days</td><td>Record answers to MOL-style questions received as text messages</td><td... |
fb294d05a9ed9031692615c6c2842cdf80418e2909214da526a87debf5fbd0d9.png | simple | <table><tr><td>Parameter</td><td>Value</td></tr><tr><td>Maximum data rate</td><td>250 kbps</td></tr><tr><td>Discovery packet time</td><td>10 s</td></tr><tr><td>Transmission power</td><td>0 dBm</td></tr><tr><td>Receiver sensitivity</td><td>−85 dBm</td></tr><tr><td>Average frame length</td><td>22 Bytes</td></tr><tr... | <table><tr><td>Parameter</td><td>Value</td></tr><tr><td>Maximum data rate</td><td>250 kbps</td></tr><tr><td>Discovery packet time</td><td>10 s</td></tr><tr><td>Transmission power</td><td>0 dBm</td></tr><tr><td>Receiver sensitivity</td><td>−85 dBm</td></tr></table> | <table><tr><td>Parameter</td><td>Value</td></tr><tr><td>Average frame length</td><td>22 Bytes</td></tr><tr><td>MAC layer</td><td>CSMA/CA</td></tr><tr><td>Maximum number of backoffs</td><td>4</td></tr><tr><td>Packet loss</td><td>1%</td></tr><tr><td>Coverage radio</td><td>50 m</td></tr><tr><td>Mode</td><td>Active</td></t... |
4fa7d322e8c516a4d7b810fb09d09bd53cf33d6e0a1912c4a8f015556d28dc08.png | simple | <table><tr><td>Primers and probes</td><td>Gene sequence</td></tr><tr><td>GAPDH sense</td><td>TGCACCACCAACTGCTTAG</td></tr><tr><td>GAPDH antisense</td><td>GGATGCAGGGATGATGTTC</td></tr><tr><td>GAPDH probe</td><td>CAGAAGACTGTGGATGGCCCCTC</td></tr><tr><td>IL-1β sense</td><td>TCCTGAACTCAACTGTGAAATGC</td></tr><tr><td>IL... | <table><tr><td>Primers and probes</td><td>Gene sequence</td></tr><tr><td>GAPDH sense</td><td>TGCACCACCAACTGCTTAG</td></tr><tr><td>GAPDH antisense</td><td>GGATGCAGGGATGATGTTC</td></tr><tr><td>GAPDH probe</td><td>CAGAAGACTGTGGATGGCCCCTC</td></tr></table> | <table><tr><td>Primers and probes</td><td>Gene sequence</td></tr><tr><td>IL-1β sense</td><td>TCCTGAACTCAACTGTGAAATGC</td></tr><tr><td>IL-1β antisense</td><td>AGCCCAGGTCAAAGGTTTGG</td></tr><tr><td>IL-1β probe</td><td>AGCAGCCCTTCATCTTTTGGGGTCCG</td></tr><tr><td>IL-6 sense</td><td>CCGGAGAGGAGACTTCACAGA</td></tr><tr><td>IL... |
eae019914a52ba4dc62549da57ee485444cea950fc1be387d30a8eb080a8c5a9.png | complex | <table><tr><td></td><td colspan="4">Mother</td><td colspan="4">Newborn</td></tr><tr><td></td><td colspan="3">DNA</td><td>Serum<sup>3</sup></td><td colspan="3">DNA</td><td>Serum<sup>3</sup></td></tr><tr><td></td><td>Cervical</td><td>Oral<sup>5</sup></td><td>Cervical/Oral</td><td></td><td>Genital</td><td>Oral</td><td>Gen... | <table><tr><td></td><td colspan="2">Mother</td></tr><tr><td></td><td colspan="2">DNA</td></tr><tr><td></td><td>Cervical</td><td>Oral5</td></tr><tr><td>HPV status</td><td>N (%)</td><td>N (%)</td></tr><tr><td>HPV+1</td><td>93 (27.9)</td><td>10 (3.0)</td></tr><tr><td>HPV-LR1,2</td><td>27 (8.1)</td><td>3 (0.9)</td></tr><tr... | <table><tr><td colspan="2">Mother</td><td colspan="4">Newborn</td></tr><tr><td>DNA</td><td>Serum3</td><td colspan="3">DNA</td><td>Serum3</td></tr><tr><td>Cervical/Oral</td><td></td><td>Genital</td><td>Oral</td><td>Genital/Oral</td><td></td></tr><tr><td>N (%)</td><td>N (%)</td><td>N (%)</td><td>N (%)</td><td>N (%)</td><... |
06b99d5eccdd013f431a7e70ab92973f5ad28a61d05f87152270e960e6d347d5.png | simple | <table><tr><td></td><td></td><td>Baseline</td><td>Reexamination</td></tr><tr><td></td><td>N</td><td>27</td><td>25</td></tr><tr><td></td><td>Mean dmft ± SD</td><td>5.1 ± 1.8</td><td>8.8 ± 0.7</td></tr><tr><td>ECC stages</td><td>Initial stage (N, %)</td><td>(27) 100%</td><td>(0) 0%</td></tr><tr><td></td><t... | <table><tr><td></td><td></td><td>Baseline</td><td>Reexamination</td></tr></table> | <table><tr><td></td><td>N</td><td>27</td><td>25</td></tr><tr><td></td><td>Mean dmft ± SD</td><td>5.1 ± 1.8</td><td>8.8 ± 0.7</td></tr><tr><td>ECC stages</td><td>Initial stage (N, %)</td><td>(27) 100%</td><td>(0) 0%</td></tr><tr><td></td><td>Circular stage (N, %)</td><td>/</td><td>(7) 28%</td></tr><tr><td></td><td>Destr... |
b21c99c994a35a71287bc59ac0e093f2f893589ec526d19367cef77b76609741.png | complex | <table><tr><td>Characteristic</td><td>Total population<sup><i>a</i></sup> [<i>n</i> (%)]</td><td>No tree canopy (%)</td><td> ≥50% impervious surface (%)</td><td>Both conditions (%)</td></tr><tr><td>Total population</td><td>81,517,417 (100.0)</td><td>42.1</td><td>62.2</td><td>36.5</td></tr><tr><td>Metro area segre... | <table><tr><td>Characteristic</td></tr><tr><td>Total population</td></tr><tr><td>Metro area segregation</td></tr><tr><td>0.13<Dm<0.40 (97 CBSAs)</td></tr><tr><td>0.40≤Dm<0.50 (105 CBSAs)</td></tr><tr><td>0.50≤Dm<0.60 (78 CBSAs)</td></tr><tr><td>0.60≤Dm<0.76 (24 CBSAs)</td></tr><tr><td>Race/ethnicity</td></tr><tr><td>Hi... | <table><tr><td>Total populationa [n (%)]</td><td>No tree canopy (%)</td><td>≥50% impervious surface (%)</td><td>Both conditions (%)</td></tr><tr><td>81,517,417 (100.0)</td><td>42.1</td><td>62.2</td><td>36.5</td></tr><tr><td colspan="4"></td></tr><tr><td>7,168,971 (8.8)</td><td>15.2</td><td>54.9</td><td>10.5</td></tr><t... |
32221a5753cd209202b3cc07b119179bf6d8d0d87d7bc926bd6f55e4bff53af1.png | simple | <table><tr><td><i>Number (%) of </i></td><td>Pre-eclamptic (<i>N </i>= 143)</td><td>Controls(<i>N </i>= 143)</td><td><i>P</i></td></tr><tr><td>Primigravidae</td><td>49(34.3)</td><td>27(18.9)</td><td>0.01</td></tr><tr><td>lack of antenatal care</td><td>21(14.7)</td><td>33(23.1)</td><td>0.02</td></tr><tr><td>Educational ... | <table><tr><td>Number (%) of</td><td>Pre-eclamptic (N = 143)</td><td>Controls(N = 143)</td><td>P</td></tr><tr><td>Primigravidae</td><td>49(34.3)</td><td>27(18.9)</td><td>0.01</td></tr><tr><td>lack of antenatal care</td><td>21(14.7)</td><td>33(23.1)</td><td>0.02</td></tr></table> | <table><tr><td>Educational level < secondary</td><td>36(25.2)</td><td>24(16.8)</td><td>0.8</td></tr><tr><td>Bednets coverage</td><td>21(14.7)</td><td>23 (16.1)</td><td>0.6</td></tr><tr><td>History of malaria</td><td>31(21.7)</td><td>11(7.7)</td><td>0.001</td></tr><tr><td>Family history of hypertension</td><td>122(85.3)... |
a5256a7d1279d96f895d8ab5c426e1f4d016cd71e5e060743b7878d1e75d949d.png | simple | <table><tr><td> </td><td>Am Δ</td><td>Cm Δ</td><td>Cf Δ</td><td> </td><td>Am Λ</td><td>Cm Λ</td><td>Cf Λ</td></tr><tr><td>O13</td><td>2.472 (3)</td><td>2.462 (3)</td><td>2.455 (4)</td><td>O1</td><td>2.507 (3)</td><td>2.496 (3)</td><td>2.476 (4)</td></tr><tr><td>O14</td><td>2.491 (3)</td><t... | <table><tr><td></td><td>Am Δ</td><td>Cm Δ</td><td>Cf Δ</td><td></td><td>Am Λ</td><td>Cm Λ</td><td>Cf Λ</td></tr><tr><td>O13</td><td>2.472 (3)</td><td>2.462 (3)</td><td>2.455 (4)</td><td>O1</td><td>2.507 (3)</td><td>2.496 (3)</td><td>2.476 (4)</td></tr><tr><td>O14</td><td>2.491 (3)</td><td>2.483 (3)</td><td>2.443 (4)</t... | <table><tr><td></td><td>Am Δ</td><td>Cm Δ</td><td>Cf Δ</td><td></td><td>Am Λ</td><td>Cm Λ</td><td>Cf Λ</td></tr><tr><td>N1</td><td>2.550 (4)</td><td>2.533 (4)</td><td>2.512 (4)</td><td>N2</td><td>2.556 (3)</td><td>2.520 (4)</td><td>2.518 (4)</td></tr><tr><td>N3</td><td>2.551 (4)</td><td>2.536 (4)</td><td>2.508 (4)</td>... |
54023a094939eaea3cc34a26f0e16afd8ebd5db406b003959308afad306a5b01.png | complex | <table><tr><td>Test</td><td>Cutoff for “abnormal”</td><td>All Stages (<i>N</i> = 5731)</td><td>Stage 1 (<i>N</i> = 4058)</td><td>Stage 2 (<i>N</i> = 981)</td><td>Stage 3 (<i>N</i> = 692)</td></tr><tr><td colspan="6">Urine Tests</td></tr><tr><td>Eosinophils</td><td>≥1 %</td><td>6.9</td><td>5.8</td><td>... | <table><tr><td>Test</td><td>Cutoff for “abnormal”</td><td>All Stages (N = 5731)</td><td>Stage 1 (N = 4058)</td><td>Stage 2 (N = 981)</td><td>Stage 3 (N = 692)</td></tr><tr><td colspan="6">Urine Tests</td></tr><tr><td>Eosinophils</td><td>≥1 %</td><td>6.9</td><td>5.8</td><td>7.2</td><td>7.5</td></tr><tr><td>Total Protein... | <table><tr><td>Test</td><td>Cutoff for “abnormal”</td><td>All Stages (N = 5731)</td><td>Stage 1 (N = 4058)</td><td>Stage 2 (N = 981)</td><td>Stage 3 (N = 692)</td></tr><tr><td colspan="6"></td></tr><tr><td>Renal Ultrasound</td><td>See Methods</td><td>34.6</td><td>40.6</td><td>23.4</td><td>34.9</td></tr><tr><td>CT Abdom... |
918a57999f4a1bf8e04d94bffb85ecb106cd98c705a206987010190390d65c31.png | complex | <table><tr><td>Variable</td><td>Median (25th, 75th percentile)</td></tr><tr><td colspan="2">Sleep</td></tr><tr><td> Time in bed (hours:minutes)</td><td>9:31 (9:02, 9:58)</td></tr><tr><td> Sleep duration (hours:minutes)</td><td>8:29 (7:59, 8:59)</td></tr><tr><td> Sleep midpoint (hours:minutes)</td><td>2:44 (2:14, 3:29)<... | <table><tr><td>Variable</td><td>Median (25th, 75th percentile)</td></tr><tr><td colspan="2">Sleep</td></tr><tr><td>Time in bed (hours:minutes)</td><td>9:31 (9:02, 9:58)</td></tr><tr><td>Sleep duration (hours:minutes)</td><td>8:29 (7:59, 8:59)</td></tr><tr><td>Sleep midpoint (hours:minutes)</td><td>2:44 (2:14, 3:29)</td... | <table><tr><td>Active transportation (minutes/day)</td><td>12.2 (5.4, 21.3)</td></tr></table> |
07771bb2485b4ee8681d498896cc9bb36b269c96800612b4aafd738869dbd21c.png | simple | <table><tr><td>Pre-SBRT factors</td><td>G4-5 RP</td><td>G0-3 RP</td><td>Total</td><td>X2 test</td><td>1-year cumulative incidence of G4-5 RP</td><td>log-rank</td></tr><tr><td>Serum KL-6</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>high value</td><td>6</td><td>17</td><td>23</td><td><i>p </i>= 0... | <table><tr><td>Pre-SBRT factors</td><td>G4-5 RP</td><td>G0-3 RP</td><td>Total</td><td>X2 test</td><td>1-year cumulative incidence of G4-5 RP</td><td>log-rank</td></tr><tr><td>Serum KL-6</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>high value</td><td>6</td><td>17</td><td>23</td><td>p = 0.0002</... | <table><tr><td>Pre-SBRT factors</td><td>G4-5 RP</td><td>G0-3 RP</td><td>Total</td><td>X2 test</td><td>1-year cumulative incidence of G4-5 RP</td><td>log-rank</td></tr><tr><td>(+)</td><td>7</td><td>6</td><td>13</td><td>p < 0.0001</td><td>57%</td><td>p < 0.0001</td></tr><tr><td>(-)</td><td>2</td><td>102</td><td>104</td><... |
36d4e747bc5f54d18586b48e5917454846ccf3f05e6577e4c4ac43570c653979.png | complex | <table><tr><td></td><td colspan="6">Cross-section 2004</td><td>Panel 2002–2004</td></tr><tr><td>Variable</td><td>Average for treated</td><td>Average for untreated</td><td>Single difference in averages</td><td>% difference</td><td>Boot-strapped Std. Err.</td><td>P-value</td><td>Double differences/differences-in-di... | <table><tr><td></td><td colspan="6">Cross-section 2004</td><td>Panel 2002–2004</td></tr><tr><td>Variable</td><td>Average for treated</td><td>Average for untreated</td><td>Single difference in averages</td><td>% difference</td><td>Boot-strapped Std. Err.</td><td>P-value</td><td>Double differences/differences-in-differen... | <table><tr><td>no. of IP admissions at commune level clinics</td><td>0.026</td><td>0.037</td><td>-0.010</td><td>-28%</td><td>0.004</td><td>0.020</td><td>0.00</td></tr><tr><td>no. of IP admissions at district hospital</td><td>0.060</td><td>0.038</td><td>0.023</td><td>60%</td><td>0.008</td><td>0.003</td><td>Not available... |
3e97976fc3b025a3c88eb47ac3b62fd383c6fb92a47a8831dc1803699315f51e.png | simple | <table><tr><td>Variables</td><td>No. of patientsn(%)</td><td>Western medicinen(%)</td><td>Chinese medicine n(%)</td><td><i>P</i>-value</td></tr><tr><td>Total</td><td>786(100)</td><td>337(42.9)</td><td>449(57.1)</td><td></td></tr><tr><td>Conventional treatment</td><td>781(99.4)</td><td>337(100)</td><td>444(98.9)</td><td... | <table><tr><td>Variables</td><td>No. of patientsn(%)</td><td>Western medicinen(%)</td><td>Chinese medicine n(%)</td><td>P-value</td></tr><tr><td>Total</td><td>786(100)</td><td>337(42.9)</td><td>449(57.1)</td><td></td></tr><tr><td>Conventional treatment</td><td>781(99.4)</td><td>337(100)</td><td>444(98.9)</td><td>0.052<... | <table><tr><td>Acupuncture and Moxibustion</td><td>11(1.4)</td><td>---</td><td>11(2.4)</td></tr><tr><td>Therapeutic Massage</td><td>40(5.1)</td><td>---</td><td>40(8.9)</td></tr><tr><td>Qigong</td><td>75(9.5)</td><td>---</td><td>75(16.7)</td></tr><tr><td>Chinese Dietary Therapy</td><td></td><td></td><td></td></tr></tabl... |
9bb2952d205a99f191a33e557ae7bb21504a34ce2d7373d2dbb5d71d63d1ee0a.png | simple | <table><tr><td>Strain of <i>C. jejuni</i></td><td>Rate of growth (μ<sub>max</sub>) in microaerobic conditions</td><td>Death times (D-values) in aerobic conditions</td></tr><tr><td>Bf</td><td>0.5763</td><td>\**</td></tr><tr><td>subsp. <i>jejuni</i> NCTC 11168</td><td>0.7714*</td><td>0.9737</td></tr><tr><td>subsp. <... | <table><tr><td>Strain of C. jejuni</td><td>Rate of growth (μmax) in microaerobic conditions</td><td>Death times (D-values) in aerobic conditions</td></tr><tr><td>Bf</td><td>0.5763</td><td>\**</td></tr></table> | <table><tr><td>Strain of C. jejuni</td><td>Rate of growth (μmax) in microaerobic conditions</td><td>Death times (D-values) in aerobic conditions</td></tr><tr><td>subsp. jejuni NCTC 11168</td><td>0.7714*</td><td>0.9737</td></tr><tr><td>subsp. jejuni 00-2538</td><td>0.9198*</td><td>1.1039</td></tr><tr><td>subsp. jejuni 0... |
397dcadb8fc4b69232d78c0e70da0f4e73cca264640dc846a56ed6007a839e0a.png | complex | <table><tr><td rowspan="3">Quality-of-care category<sup>a</sup></td><td colspan="6">Summary score</td></tr><tr><td colspan="3">Baseline</td><td colspan="3">End of the study</td></tr><tr><td>Intervention group, mean (SD)</td><td>Control group, mean (SD)</td><td>Intervention versus control group, mean difference (95% CI)... | <table><tr><td rowspan="3">Quality-of-care categorya</td><td colspan="6">Summary score</td></tr><tr><td colspan="3">Baseline</td><td colspan="3">End of the study</td></tr><tr><td>Intervention group, mean (SD)</td><td>Control group, mean (SD)</td><td>Intervention versus control group, mean difference (95% CI)</td><td>In... | <table><tr><td>Information systems and statistics</td><td>1.85 (0.44)</td><td>1.70 (0.53)</td><td>0.15 (−0.30 to 0.60)</td><td>2.68 (0.24)</td><td>1.55 (0.52)</td><td>1.26 (0.85 to 1.66)</td></tr><tr><td>Drugs and equipment</td><td>2.27 (0.61)</td><td>2.00 (0.73)</td><td>0.27 (−0.36 to 0.90)</td><td>2.94 (0.11)</td><td... |
5f115f3814e4534701b6882a32c4186f929761ab1b216ffe027fa2c74d4beafe.png | complex | <table><tr><td></td><td colspan="3">SCC</td></tr><tr><td>Herd size</td><td>< = 200</td><td>201-400</td><td>> 400</td></tr><tr><td>Q1</td><td>35.52</td><td>42.35</td><td>22.12</td></tr><tr><td>Q2</td><td>33.06</td><td>46.99</td><td>19.96</td></tr><tr><td>Q3</td><td>31.38</td><td>49.47</td><td>19.15</td></tr><tr><t... | <table><tr><td></td><td colspan="3">SCC</td></tr><tr><td>Herd size</td><td>< = 200</td><td>201-400</td><td>> 400</td></tr><tr><td>Q1</td><td>35.52</td><td>42.35</td><td>22.12</td></tr></table> | <table><tr><td></td><td colspan="3">SCC</td></tr><tr><td>Herd size</td><td>< = 200</td><td>201-400</td><td>> 400</td></tr><tr><td>Q2</td><td>33.06</td><td>46.99</td><td>19.96</td></tr><tr><td>Q3</td><td>31.38</td><td>49.47</td><td>19.15</td></tr><tr><td>Q4</td><td>26.50</td><td>54.74</td><td>18.76</td></tr></table> |
a22955d998f27a1d688fc11e4aaca3e73da42a5aac7e4977380bd8881961373c.png | simple | <table><tr><td>Level of Adaptation to Heat</td><td>% Who Reported Adverse Health Impacts</td><td>Confidence Interval</td><td>Coeff. of Variation</td><td>Odds Ratio</td><td>Confidence Interval</td><td>Pr > χ<sup>2</sup></td></tr><tr><td>Individuals who adapt well</td><td>45.77</td><td>(41.78–49.76)</td><td... | <table><tr><td>Level of Adaptation to Heat</td><td>% Who Reported Adverse Health Impacts</td><td>Confidence Interval</td><td>Coeff. of Variation</td><td>Odds Ratio</td><td>Confidence Interval</td><td>Pr > χ2</td></tr><tr><td>Indiv</td><td></td><td>(41.7</td><td></td><td></td><td>(1.1</td><td>0.</td></tr></table> | <table><tr><td>iduals who adapt well</td><td>45.77</td><td>8–49.76)</td><td>4.44</td><td>1.37</td><td>3–1.66)</td><td>0011</td></tr><tr><td>Individuals who do not adapt as well</td><td>38.11</td><td>(33.66–42.56)</td><td>5.95</td><td>1.00</td><td></td><td></td></tr></table> |
963edf2849e67766811093909ce7efc133f824a65c12e7899a6249c212f76a84.png | simple | <table><tr><td></td><td>Blood</td><td>Brain</td><td>Liver</td><td>Tongue</td><td>Skin</td><td>Lung</td><td>Muscle</td><td>Intestine</td><td>Tumour</td></tr><tr><td>L-BPA (μg/g)</td><td>13.42 ± 1.26</td><td>4.97 ± 0.54</td><td>12.11 ± 1.82</td><td>13.62 ± 5.15</td><td>15.65 ± 2.77</td><td>1... | <table><tr><td></td><td>Blood</td><td>Brain</td><td>Liver</td><td>Tongue</td><td>Skin</td><td>Lung</td><td>Muscle</td><td>Intestine</td><td>Tumour</td></tr><tr><td>L-BPA (μg/g)</td><td>13.42 ± 1.26</td><td>4.97 ± 0.54</td><td>12.11 ± 1.82</td><td>13.62 ± 5.15</td><td>15.65 ± 2.77</td><td>15.82 ± 1.51</td><td>12.41 ± 1.... | <table><tr><td>L-FBPA (μg/g)</td><td>13.19 ± 1.18</td><td>4.61 ± 2.28</td><td>15.63 ± 3.15</td><td>12.14 ± 1.08</td><td>13.75 ± 3.08</td><td>14.78 ± 1.64</td><td>9.69 ± 1.3</td><td>15.33 ± 0.88</td><td>20.17 ± 6.49</td></tr><tr><td>p value</td><td>0.81</td><td>0.81</td><td>0.18</td><td>0.61</td><td>0.45</td><td>0.43</t... |
529aeace101415f48ef3b932fed92a1aaf4406218a557ff474a0dac0535fd7eb.png | complex | <table><tr><td></td><td>Kidney</td><td>Kidney pancreas</td></tr><tr><td>Number recruited</td><td>42</td><td>19</td></tr><tr><td>Sex male/female</td><td>31M/11F</td><td>9M/10F</td></tr><tr><td>Median age (range)</td><td>54 (26–74)</td><td>47 (30–59)</td></tr><tr><td colspan="3">Donor type</td></tr><tr><td>Li... | <table><tr><td></td><td>Kidney</td><td>Kidney pancreas</td></tr><tr><td>Number recruited</td><td>42</td><td>19</td></tr><tr><td>Sex male/female</td><td>31M/11F</td><td>9M/10F</td></tr><tr><td>Median age (range)</td><td>54 (26–74)</td><td>47 (30–59)</td></tr></table> | <table><tr><td></td><td>Kidney</td><td>Kidney pancreas</td></tr><tr><td colspan="3">Donor type</td></tr><tr><td>Living (male/female)</td><td>16 (11M/5F)</td><td>n/a</td></tr><tr><td>DBD (male/female)</td><td>11 (7M/4F)</td><td>16 (7M/9F)</td></tr><tr><td>DCD (male/female)</td><td>15 (13M/ F)</td><td>3 (2M/1F)</td></tr>... |
e2f612d274a1e8229b8d463f5ed036805eb3979dd4aeece33f00d2d695bd4762.png | complex | <table><tr><td colspan="2">Demographic</td><td>Physicians (n = 13)</td><td>Nursing staff (n = 13)</td><td>Overall (n = 26)</td></tr><tr><td rowspan="2">Sex</td><td>Male</td><td>4</td><td>1</td><td>5</td></tr><tr><td>Female</td><td>9</td><td>12</td><td>21</td></tr><tr><td>Age (yr)</td><td>Mean (range)</td><td>45 (25R... | <table><tr><td colspan="2">Demographic</td><td>Physicians (n = 13)</td><td>Nursing staff (n = 13)</td><td>Overall (n = 26)</td></tr><tr><td>Sex</td><td>Male</td><td>4</td><td>1</td><td>5</td></tr></table> | <table><tr><td>Sex</td><td>Female</td><td>9</td><td>12</td><td>21</td></tr><tr><td>Age (yr)</td><td>Mean (range)</td><td>45 (25–60)</td><td>45 (24–61)</td><td>45 (24–61)</td></tr><tr><td>Years of professional experience</td><td>Mean (range)</td><td>15 (0–36)</td><td>17 (0–32)</td><td>16 (0–36)</td></tr><tr><td rowspan=... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.